LLS Annual Report 2022

2022 ANNUAL REPORT

Big Dreams,

Big Dreams

You may say that we are

dreamers…

In 1949, The Leukemia & Lymphoma Society (LLS) was founded on a dream, by parents who’d lost a son to acute lymphoblastic leukemia and sought to spare others their pain.

Since then, LLS has never stopped dreaming. Our bold achievements continue to push boundaries as we seek cutting edge treatments and cures and work to improve quality of life for patients and their families.

Our progress has been nothing short of astonishing.

2022 was no exception. Take a look...

BOLD PROGRESS In 2022, we: ... witnessed the FDA approval of 14 new blood cancer treatment options, many because of longstanding LLS support ... advanced promising blood cancer research worldwide by funding more than 117 scientists and investing in 17 Therapy Acceleration Program® (TAP) partners … deepened our commitment to transform treatment and care for kids with the launch of The Dare to Dream Project … launched our PedAL Master Clinical Trial to expedite safer, more targeted treatments for pediatric acute leukemia ... advanced health equity through multifaceted efforts across research, education & support, and advocacy efforts. ... increased financial assistance funding for patients and families, by nearly 60% compared to last year ... expanded offerings and increased education and support services for patients, survivors, families, and healthcare professionals … advocated by raising the voices of blood cancer patients and their families leading to federal and local victories

DEAR

Friends,

With your help, we are creating a world where cancer patients not only survive their blood cancer but thrive in their lives after treatment.

The evolution of new blood cancer therapies has been breathtaking—spanning the gamut from genetargeted therapies to cell-based immunotherapies— and providing remarkable benefit to patients.

The Leukemia & Lymphoma Society (LLS) is the largest nonprofit funder of blood cancer research, having invested more than $1.6 billion since our founding. In the last six years alone, we have helped advance more than 70% of the 110 (!) blood cancer treatment options approved by the U.S. Food and Drug Administration.

But LLS does more than fund pioneering research. We’re here to support patients and families through every part of their blood cancer experience— from diagnosis through treatment and beyond. We provide the reassurance, free personalized information and financial assistance they need. And we advocate for policies that break down barriers to care, so it’s more accessible and affordable for those in underserved communities.

At LLS, we envision a world without blood cancer. We work toward that dream every day and have made bold progress in our mission to cure blood cancers and improve the quality of life for patients and their families.

I am exceptionally proud of what we’ve accomplished together and excited about all that’s on the horizon.

Louis J. DeGennaro, PhD | President and Chief Executive Officer

DEAR

Friends,

In 2004, I was diagnosed with acute myeloid leukemia (AML) and given a 40% chance to live. I was one of the lucky survivors—thanks to pioneering scientists who created medicine that cured me. Once in remission, I resolved to do whatever I could to help blood cancer patients and to accelerate the development of new treatments so that more patients could survive these terrible blood cancers.

I searched for a nonprofit to support and found in LLS an organization that not only deploys its donations responsibly and effectively in service of patients but is transforming blood cancer treatment and care.

I’ve been fundraising and volunteering for LLS ever since—first as a member of the Georgia board, then as part of LLS’s national board, and now proudly as National Board Chair. I believe there’s no better use of our time and talents than helping others.

Your support has lifesaving and life-changing power. Through your generosity of heart and spirit, you are helping LLS ensure a future of expanded hope for all blood cancer patients and those who love and care for them.

I am grateful for you and the sacrifices you make to help others. Thank you.

… continued to raise the bar on our fundraising efforts across our signature campaigns, corporate partnerships, and advancement efforts

Jeff Sachs | Chair of the Board 2022 Annual Report | 1

Big Dreams, BOLD PROGRESS

ZARIYAH

ALL survivor

ARYAN

ALL survivor

PAIGE

SAMUEL

ALL survivor

ALL survivor

ALANA

Hodgkin lymphoma survivor

ETHAN

ALL survivor

Transforming Treatment and Care for Kids with Blood Cancer THE

Big Dream

To transform treatment and care for kids with blood cancer…so they not only survive but thrive in their lives after treatment.

Our Bold Progress At LLS, our pediatric triumphs help make the case that dreams can come true. Cancers previously associated with nearly certain death are now highly survivable. Through our Children’s Initiative, we have supported breakthrough research, developed programs to support pediatric patients and families, and sparked interest among leading experts in pediatric oncology. But LLS knows there is more to accomplish, and in 2022, we deepened our commitment to further galvanize progress with the next phase of our Children's Initiative: The Dare to Dream Project. With an expanded vision, and a name that reflects our belief that this big, bold project is achievable, we are aiming higher than ever before: a total transformation of treatment for children with blood cancer through a 360-degree, holistic approach. With a five-year fundraising goal of $175M, our efforts are in full swing to...

“

Children have a unique disease with unique targets. Efforts like PedAL are critical to address the specific needs of our youngest, most vulnerable patients by using new, safer therapies.

— Dr. Todd Cooper, section chief of Pediatric Oncology; director of the Pediatric Leukemia/Lymphoma Program; co-director of the High-Risk Leukemia Program at Seattle Children’s; PedAL screening trial lead

2 | The Leukemia & Lymphoma Society

”

...Bring Safer Treatments to Children Through Our PedAL Master Clinical Trial LLS is committed to ensuring long-term quality-of-life for the youngest blood cancer patients. Our goal is to uncover less toxic individualized therapies that target cancer cells, spare healthy cells, and avoid adverse long-term health consequences. The 2022 launch of LLS’ Pediatric Acute Leukemia (PedAL) Master Clinical Trial marked a critical milestone in this quest. This unprecedented international collaborative effort between LLS, the National Cancer Institute (NCI), the Children’s Oncology Group (COG), and other partners and sponsors breaks new ground, bringing precision medicine to the treatment of pediatric relapsed acute leukemia.

Rather than a “one size fits all” approach, PedAL uses genomics and other biomarkers to customize treatment, allowing innovative therapies to be matched to patients based on their unique tumor biology. A wide range of trial screening locations—spanning Europe, Australia, New Zealand, Canada, and over 200 U.S. sites—ensures widespread participation.

Arkansas Children’s Hospital became the first U.S. therapeutic trial site in 2022, with more to come.

Two LLS-supported digital breakthroughs led by the University of Chicago are contributing to PedAL’s robust data infrastructure, allowing for standardized assessment of tumor biology and global data sharing: • GEARBOx (Genomic Eligibility Algorithm at Relapse for Better Outcomes): a search tool that helps physicians match relapsed leukemia patients to available clinical trials • D ata Commons: a platform that ensures consistency in global data reporting, analysis, and access

40%

of pediatric cancers are blood cancers

Approximately

80%

of childhood cancer survivors develop chronic health issues from treatment

Only

5%

of cancer drugs have been approved for first-time use in children

...Expedite Groundbreaking Pediatric Blood Cancer Research Through Increased Investment

Cayden & Courtney Addison MEET

One Family’s Journey Toward Hope When three-year-old Cayden Addison of Chesapeake, VA, was diagnosed with high-risk Philadelphia Chromosome-positive acute lymphoblastic leukemia (ALL), his mom Courtney “sobbed like never before.”

From that point forward, Courtney knew she’d embrace a dual mission: to learn all she could about blood cancer, while getting Cayden through the surgeries, chemotherapy, and countless overnight hospital stays he would need to endure.

A recommendation from a friend connected the Addisons to LLS’ flagship Light The Night fundraising campaign and before long, Cayden was named the campaign’s 2021 National Honored Hero, serving as an LLS Ambassador of Hope. Involvement with LLS has provided needed support for Courtney during Cayden’s cancer journey.

“Through LLS, I’ve learned there is a whole community of people out there who were just as passionate and dedicated to fighting this disease as I am.” Cayden finished treatment in April 2022, and Courtney has drawn hope and strength from a “brave, strong, resilient, and grateful” Cayden… and from LLS. Courtney now serves as a Dare to Dream Ambassador, sharing her family’s story to raise awareness about LLS and the need for better treatments.

“I know LLS’ great work is helping bring us closer to a world where no parent has to hear, ‘your child has cancer.’”

LLS seeks to improve our understanding of all pediatric blood cancers and develop better, safer treatments so as many patients as possible survive without lifelong health challenges. We have increased our pediatric research investment significantly, with a commitment to invest more than $52M in pediatric grants by 2027. In FY22 alone, our $8.4M commitment to pediatric blood cancer projects represented a four-fold increase compared to FY21. Like PedAL, all our laboratory research efforts explore therapeutics that consider the unique genetics of pediatric blood cancers and replace “one size fits all” chemotherapy with targeted treatments. We are funding over 30 pediatric-specific grants, including work focused on long-term side effects of treatment and improved relapse detection. ...Grow Our Education & Support Services To provide 360-degree support for pediatric patients and families, we are expanding our educational resources and support services, with the emphasis on providing guidance, information, and comfort during treatments…and beyond. In 2022, we introduced our hardcover book trilogy, Stars Will Twinkle, The Sun Will Shine, available in English and Spanish, to educate pre-kindergarten children about a leukemia diagnosis—the first book in the U.S. to do so. Further, our Caregivers’ Guide to Navigating Childhood and Adolescent Blood Cancers, a digital “flip book” embedded with videos, was selected as a Gold Award Winner in the Spring 2022 Digital Health Awards. Additionally, we added specially trained pediatric nurse navigators to help families navigate the clinical trial process within our LLS Clinical Trial Support Center (CTSC). ...Drive Advocacy for Young Patients and Families For decades, LLS has fought to ensure access to affordable, quality healthcare for kids and young adults with blood cancer. Moreover, we’ve pushed to change outdated policies that stall pediatric drug development. In 2022, volunteer advocates and staff working closely with allies helped secure $160M in federal funds for pediatric cancer research nationwide. That funding was the result of hundreds of constituent meetings with lawmakers emphasizing the importance of those dollars for patients. LLS advocates also sent thousands of letters to lawmakers and held hundreds of meetings, resulting in Congress extending the Childhood Cancer STAR Act—the most comprehensive childhood cancer bill ever—for another five years.

2022 Annual Report | 3

Big Dreams, BOLD PROGRESS

ROMMY

CRUZ

DAVE

TOWANNA

lymphoma survivor

AML survivor

KENNETH

ERIC

CLL survivor

lymphoma survivor

non-Hodgkin lymphoma survivor

ALL survivor

Breakthrough Research: Improving Treatments and Enhancing Quality of Life RESEARCH INVESTMENT:

$

233.8 MILLION

62M 44M 32M 26M

$

TOTAL MULTI-YEAR FUNDING IN RESEARCH

$

$

$

$

AML

AGGRESSIVE NHL

MYELOMA

MDS/MPNS

26.5%

18.6%

13.5%

11.2%

19M 16M 14M 10M $

$

$

$

5M

$

5M

GENERAL LYMPHOMA

INDOLENT NHL

ALL

GENERAL LEUKEMIA

CLL/SLL

HODGKIN LYMPHOMA

7.9%

6.9%

6.1%

4.4%

2.2%

2.1%

$

2M CML 0.7%

Any discrepancies are due to rounding; total investment=$233.8M.

Advancing Science THE

Big Dream

To discover breakthrough treatments and cures for all blood cancers and improve quality of life during and after treatment…bringing new hope to even more patients.

Our Bold Progress

Our Strategic Approach

LLS is the largest nonprofit funder of blood cancer research and has been instrumental in the development of nearly every breakthrough in its treatment. Because of LLS, blood cancers that were once fatal are now treatable and even curable.

LLS has a history of strategic investment in the most innovative and promising blood cancer research, leading to an unparalleled record of success. Today, blood cancer patients are living longer, better lives because LLS has supported generations of remarkable scientists leading to extraordinary advances. We put our support where it will make a real difference:

LLS is proud of our role in advancing treatments that have exponentially improved survival rates and quality of life for patients with many types of blood cancer, but there is much more for us to accomplish.

4 | The Leukemia & Lymphoma Society

• L ast year alone, LLS Research Grants supported 117 scientists at the world’s most prestigious institutions to advance next-generation approaches including immunotherapy, gene editing and precision medicine.

• T herapy Acceleration Program® (TAP) is a unique venture philanthropy initiative partnering directly with biotechnology companies to invest in innovative therapies to change the standard of blood cancer care.

Since 2017, four TAP-supported therapies have been approved by the FDA or added to guidelines that drive treatment and insurance coverage decisions. Currently, there are more than 20 active clinical studies of TAP-supported therapies, including four that, if successful, will lead to additional new FDA approvals.

MEET

William Yank

Bold New Therapies Help Spare Young Patient’s Life Halfway through a summer internship in Washington, D.C., Indiana resident William Yank was celebrating his 21st birthday when he started to feel “off.” Low energy and odd hand pains progressed to a sore throat and delirium, followed by a diagnosis of acute lymphoblastic leukemia (ALL). An accompanying infection led to septic shock and a potentially lethal cascade of symptoms as his organs were shutting down.

Transferred to Johns Hopkins Medical Center in Baltimore, William’s life was saved.

“Through rigorous amounts of physical therapy, chemo, pain medication, and sheer will, I was able to leave a month and a half later,” William said. When additional chemotherapy proved insufficient to keep his cancer at bay, it was time for cutting edge CAR T-immunotherapy, which LLS helped fund. After one month back at Hopkins, remission was achieved. Sadly, six months later, William learned his cancer had returned, calling for another dose of CAR T cells.

Back in remission, William returned home for his senior year of college, but within months, his cancer was back. Another immunotherapy was used to prepare him for a stem cell transplant with his sister as donor. Now in long-term remission, William proudly advocates for other cancer and chronically ill patients through ‘The Illest’ cancer podcast which he created and co-hosts, and via TikTok videos.

• The first of their kind LLS-Led Master Clinical Trials, Beat AML® and PedAL (Pediatric Acute Leukemia), have brought together a broad, global collaboration with some of the best and brightest industry leaders and academic institutions to fundamentally change treatment for adults and children.

Here are some highlights of how LLS is shaping the research landscape and the exciting work ongoing: Immunotherapy Immunotherapy harnesses the power of the immune system to attack cancer. LLS has invested more than $100 million in immunotherapy and our commitment is stronger than ever.

Our early and sustained investment was vital to the development of CAR T-immunotherapy, which re-engineers a patient’s own immune T cells to fight their cancer.

With 12 approvals since 2017, and 4 in 2022 alone, CAR T is providing a lifeline for patients with acute lymphocytic leukemia, multiple myeloma and non-Hodgkin lymphomas. This year also saw approval of a first-in-class bispecific antibody to treat multiple myeloma. Bispecific antibodies attach to both tumor cells and immune T cells to activate them to attack the cancer.

Our ongoing investments are aimed at making immunotherapy available earlier in treatment and to patients with more types of blood cancer, shortening the time it takes to deliver CAR-T, and harnessing parts of the immune system beyond T cells to make treatments even better and longer lasting.

Precision Medicine Blood cancer treatment has been revolutionized, thanks to precision medicine. By attacking cancer cells based on their unique genetic characteristics while leaving healthy cells alone, precision medicine helps to avoid short- and long-term side effects of conventional “one-size-fits-all” chemotherapies.

The FDA approved 13 new precision medicine treatments for blood cancers this year. We helped advance many of these new drugs and continue to invest in research to better understand the genetic underpinnings of blood cancer, discover new targets, and uncover new combination therapies. Through LLS’s Beat AML® and PedAL master clinical trials, LLS is unlocking the power of

2022 Annual Report | 5

precision medicine to transform treatment. PedAL launched this year (read more on page 2) while Beat AML,® launched in 2016, continues to generate strong results, showing superior survival rates and better quality of life when genomic analysis is used to match patients to gentler, targeted therapies.

Impact of Covid Throughout the pandemic, the LLS National Patient Registry, a project of the Michael J. Garil Patient Data Collective, has generated essential information about the impact of COVID-19 and COVID-19 vaccines on the blood cancer community.

MEET

Dr. Noha Sharafeldin

LLS Propels Young Scientist’s Bold Progress While studying medicine in her native Egypt, and later for her PhD in Canada, Dr. Noha Sharafeldin sought to understand how certain factors— including genetics—make some people more susceptible to cancer. During her postdoctoral studies at the University of Alabama at Birmingham (UAB), her blood cancer outcomes and survivorship research caught the attention of LLS, earning her a Career Development Program (CDP) Special Fellow Award in 2018.

Dr. Sharafeldin credits LLS with “providing financial support and stability” that kept her “on track and focused” as she researched how to reduce long-term cognitive effects of bone marrow transplants on blood cancer survivors.

“The CDP Fellow award was absolutely instrumental to my career,” she said, explaining that, besides funding, the recognition gave her “confidence…and the will to overcome challenges as an international scholar.”

Dr. Sharafeldin gives back to LLS as a member of her local LLS Students of the Year leadership team. Now an assistant professor of medicine at UAB and member of its Institute for Cancer Outcomes and Survivorship, she was recognized again in 2022, receiving the LLS-CDP Special Fellow Achievement Award. As one of four grantees honored as most impressive in the final year of their funding, Dr. Sharafeldin is hopeful that, as the survivor population grows, “efforts to reduce the negative impact on quality-of-life after cancer will be at the forefront,” adding that she will be “eternally grateful watching LLS move our field forward.”

6 | The Leukemia & Lymphoma Society

Our findings have helped patients and their families make informed vaccine and prevention choices and have shaped public policies designed to help them stay safer during this uniquely challenging time. Our current focus is on reporting critical data on breakthrough infections in blood cancer patients, including those who have received monoclonal antibodies to reduce the chances of COVID-19 infections.

Prevention The ability to intercept blood cancer at its earliest, most treatable stages, or even before it occurs, is becoming increasingly possible, thanks to high-powered genetic analysis that can identify patients with cancer-causing blood gene mutations.

Earlier this year, LLS-supported research reported that first responders to the World Trade Center attack on 9-11 have significantly higher rates of mutations in their blood associated with certain blood cancers, providing rationale for enhanced screening and prevention efforts for these heroes. With our support, an LLS advocate led an effort to secure an additional $1 million grant from New York State to help fund this project.

LLS is also funding a clinical study in Iceland to identify patients with an early precursor of multiple myeloma, known as MGUS (monoclonal gammopathy of undetermined significance), and follow their progression to myeloma. Iceland’s unique nationalized health system allows for tracking MGUS progression in a large population.

Gene Editing The ability to edit or replace defective genes is a promising new area for blood cancer discoveries and therapies. LLS is once again at the forefront by funding research using gene editing approaches to find new treatments and improve existing treatments. LLS TAP partner Caribou Biosciences, for example, is exploring using next-generation CRISPR genome-editing to eliminate a gene that shuts down T-cells, to hopefully sustain or even boost activity of CAR T cell treatment.

LLS HAS INVESTED MORE THAN

$1.6 BILLION

IN RESEARCH FOR ALL TYPES OF BLOOD CANCER SINCE OUR FOUNDING

LLS HELPED ADVANCE

3 OF EVERY 4

BLOOD CANCER TREATMENTS APPROVED BY THE FDA IN THE LAST 6 YEARS

Funding The Next Generation Of Breakthroughs LLS funds innovative research and researchers across the U.S. and the world who are working on better treatments for all types of blood cancer, including...

Omar Abdel-Wahab, MD

Matteo Bellone, MD

Timothy Graubert, MD

Richard Lock, PhD

Julia Maxson, PhD

Catherine Smith, MD

Srividya Swaminathan, PhD

Ryan Wilcox, MD, PhD

Memorial Sloan Kettering Cancer Center Developing new targeted therapies for every stage and subtype of hairy cell leukemia

Knight Cancer Institute, Oregon Health & Science University Identifying multipronged strategies to improve outcomes for patients with myeloid cancers, such as AML and chronic neutrophilic leukemia

Fondazione Centro San Raffaele, Italy Investigating whether a vaccine to modulate bacteria in the gut can block the progression of multiple myeloma to full-blown disease

University of California, San Francisco Working to identify the genetic mutations that can make acute myeloid leukemia resistant to conventional therapy, and developing novel treatment strategies

Massachusetts General Hospital Building the foundational science needed to launch multiple clinical trials to test therapies for patients with mutations that make treatment more challenging

Beckman Research Institute of the City of Hope Studying how cancer cells avoid immune system detection in children and adults with lymphoid malignancies including acute lymphoblastic leukemia and lymphomas

The University of New South Wales, Australia Testing a potential treatment for ALL, the most common pediatric blood cancer and one of the most common causes of death from disease in children

University of Michigan Investigating a novel therapeutic target to treat an aggressive group of non-Hodgkin lymphomas called T-cell lymphomas

2022 Annual Report | 7

LLS-funded physician-scientist, pediatric oncologist Dr. Rayne Rouce works on new ways to use the immune system to target and kill blood cancers.

2022 New FDA Approvals Leukemia

Lymphoma

Acute Myeloid Leukemia with IDH1 mutation

Follicular Lymphoma

Olutasidenib (Rezlidhia™) Ivosidenib (Tibsovo®) in combination with azacitidine

Juvenile (Pediatric) Myelomonocytic Leukemia Azacitidine (Vidaza®)

Multiple Myeloma Relapsed/Refractory (advanced) disease Teclistamab-cqyv (Tecvayli™) ■ Ciltacabtagene autoleucel (Carvykti™) ■

8 | The Leukemia & Lymphoma Society

Tisagenlecleucel (Kymriah®) ■ Mosunetuzumab (Lunsumio®) ■

Pediatric Classical Hodgkin Lymphoma Brentuximab vedotin (Adcetris®) ■ in combination with chemotherapy

Large B-cell Lymphoma (second line treatment) Lisocabtagene maraleucel (Breyanzi®) ■ Axicabtagene ciloleucel (Yescarta®) ■

■ Indicates LLS Support Other Blood Cancers and Conditions Pediatric Graft Vs Host Disease Ibrutinib (Imbruvica®)

Histiocytic Neoplasms Cobimetinib (Cotellic®) ■

Myelofibrosis (high-risk primary or secondary) Pacritinib (Vonjo™)

Myeloid/Lymphoid Neoplasms with FGFR1 mutation Pemigatinib (Pemazyre®)

Progress Across All Blood Cancers Multiple Myeloma

Lymphoma

In 2022, two new treatments were approved to treat multiple myeloma—a CAR T-cell treatment in March and the first bispecific antibody in October. These approvals, both immunotherapy drugs, reinforce the long-term LLS strategy of investing in ways to activate the immune system to cure cancer. The new drugs take us one step closer to long-term control of multiple myeloma, but there is much more to do as we work towards a cure.

CAR T-cell therapies continue to redefine our approach to many types of lymphoma. As one of the earliest supporters of this groundbreaking immune-based approach, we were excited to see CAR T-therapies approved this year for use earlier in the treatment of large B-cell lymphoma and follicular lymphoma, offering patients a superior long-term remission rate compared to other therapies and the hope of a potential cure. Our work does not stop there. With $83 million dedicated to lymphoma research, we continue to push boundaries to find better and safer treatments for Hodgkin lymphoma and all forms of non-Hodgkin lymphoma. LLS has placed special emphasis on developing new therapies for mantle cell lymphoma, which includes the use of new precision medicines and therapies.

LLS has more than $31 million committed to more than 30 active laboratory and clinical research projects to improve the health and quality of life of patients with multiple myeloma.

We search worldwide for the most innovative ideas, leading us to support a key clinical trial in Iceland that will lead to blocking the progression from pre-myeloma to myeloma. Additional work is focused on identifying mutations that cause the disease, and understanding why patients become resistant to certain treatments, and supporting clinical trials that will overcome resistance to currently approved immunotherapies.

Leukemia With more than $93 million committed to leukemia research, LLS continues to lead the way toward cures, including with targeted therapies that zero in on specific genetic traits of cancer. We are working toward new standards of care, especially for children, that move away from toxic chemotherapies and toward precision approaches that target cancer cells without harming the rest of their bodies.

Newly approved drugs this year for leukemia include a new treatment for a difficult and rare form of childhood leukemia that most often occurs in children before age 4, and a new targeted combination therapy for patients 75 and older with newly diagnosed AML with an IDH1 gene mutation.

THE

Other Blood Cancers and Conditions LLS proudly dedicates resources and expertise to research to improve the outlook for people with every type of blood cancer. Our efforts to identify and understand genetic mutations at work in blood cancer laid the foundation for 2022 drug approvals for patients with myeloproliferative neoplasms (MPNs) driven by mutations in genes called JAK2, IRAK1, CSFR1 and FGFR1. These gene names may sound like “alphabet soup,” but identifying these genes and developing drugs that target them is vital to affected patients. LLS has more than $30 million committed to research into MPNs and $26 million committed to improving our ability to diagnose, treat and stop myelodysplastic syndromes from progressing to acute leukemia. Our funding also played a key role in approval of a new precision medicine treatment to control histiocytic neoplasms.

LLS funded key laboratory and clinical research leading to approvals for children and adults with this rare cancer.

Dream Continues...

Our growing knowledge is paving the way for newer, even more precise immunotherapy and precision medicine approaches, including an increasing number of CAR-T therapies, bispecific antibodies, and other immune-based therapies that can treat even more types of blood cancer and earlier in the course of the disease.

DAMION

myeloma survivor

2022 Annual Report | 9

Big Dreams, BOLD PROGRESS

ALICE

CLL survivor

AINSLEY

Hodgkin lymphoma survivor

ZAINAB

leukemia survivor

YOLANDA

PAUL

multiple myeloma survivor

non-Hodgkin lymphoma survivor

SHELLEY

Hodgkin lymphoma survivor

360 Degree Support for the Blood Cancer Community THE

Big Dream

That all blood cancer patients—no matter who they are or where they live— receive the best care and support they need from diagnosis to treatment to survivorship.

Our Bold Progress At LLS, we recognize the financial and emotional impact a blood cancer diagnosis can have on patients and families. We also realize how difficult it is to navigate a complex healthcare system after diagnosis—especially given that there are many barriers to health equity. Our goal is to help ease these burdens by providing all-around support and advocacy for patients, survivors, caregivers, and families. In 2022, we made impressive headway.

Advancing Health Equity LLS has a long-standing commitment to equity in blood cancer care. Guided by our fundamental belief that everyone deserves the best possible treatment, we have instituted multiple efforts to break down barriers and address the needs of underserved populations.

In 2022, we made meaningful progress as we… ...Increased Funding for Our Equity in Access Research Program To overcome disparities in health care, we must understand the obstacles. In 2022, we launched this signature program as part of our longstanding effort to understand barriers in blood cancer treatment and identify solutions to improve access to care. We granted over $1.3 million in combined funding for three teams of preeminent researchers, charged with uncovering the root causes of health disparities— information we can use to urge lawmakers and healthcare practitioners to affect positive change.

10 | The Leukemia & Lymphoma Society

“

Blood cancer is hard enough for patients and their families, and obstacles make it even harder.

We want to put an end to these disparities. That’s why LLS created the Equity in Access Research Program.

— Gwen Nichols, MD, LLS Chief Medical Officer

”

...Expanded Latino Outreach To better serve the large and growing Hispanic population, we established a Latino Outreach Pilot program in the Greater Los Angeles and Central Valley areas of California. Input from local stakeholders, including patients, helped shape the pilot activities, including in-person and online Spanish-language programs. These initial efforts reached over 100,000 individuals affected by blood cancer, along with Promotores (community health workers), and healthcare providers. Evaluative data will guide the program's future expansion to more cities.

MEET

Charlie Huang

Charlie’s Law: How one LLS advocate’s work is helping improve diversity of the National Bone Marrow Registry.

After receiving a leukemia diagnosis, Santa Clara County Deputy District Attorney Charles Huang’s best shot for survival was a bone marrow transplant. As an ethnic minority, Huang faced the heightened challenge of locating a “best match” donor from a similar ethnic background. His chances of finding an adult match with a donor of Asian descent, like himself, were estimated at 47%, versus 79% for Caucasian patients. While Huang’s brother was ultimately able to serve as his donor, he still dreamed of a way to ease the bone marrow matching process for other ethnic minorities.

From his hospital bed, Huang drafted what would become “Charlie’s Law”— legislation signed into law by California Gov. Gavin Newsom in 2022, enabling California residents to register for the National Marrow Donor Program when they apply for their driver’s licenses or ID cards.

He partnered with LLS—a leading advocacy organization with allies across California— to help pass the law. “Given the genetic diversity of California…this is going to save lives,” Huang said. Since the registry is national in scope, increasing the number of donors in California can benefit patients throughout the country. But it is Huang’s hope that other states will follow suit to further expand the number of registered donors—and the availability of lifesaving treatment—across the U.S.

HERIBERTO CASTANEDA AND HIS WIFE Burkitt lymphoma survivor

...Improved Access and Diversity in Clinical Trials LLS believes that the full benefit of cancer research will not be realized until clinical trial participation better reflects the diversity of the U.S. population. We are dedicated to addressing barriers to clinical trial participation to accelerate scientific progress and to provide patients with access to novel therapies and approaches.

Our efforts ramped up in 2022, with the expansion of our LLS IMPACT (Influential Medicine Providing Access to Clinical Trials) Research Grants award. This program is designed to increase the enrollment of individuals from underrepresented communities in clinical trials. This year, we added three more grants expanding this “hub and spoke” model in six geographic locations across the country. The program now provides six “hubs” or major cancer centers with funding to set up networks of trial sites in local community-based hospitals and clinics with significant underserved populations.

Furthermore, we continued to provide financial support to ease the burden of trial participation, particularly for lower income patients and families.

2022 Annual Report | 11

...Sustained Advocacy Efforts LLS continued to take our messages to influential lawmakers who can advance policies that improve health equity. We are proud to have played a key role in securing: • P assage of landmark clinical trial diversity reforms: LLS helped secure the passage of new policies that will enable more patients—including those from groups underrepresented in trials—to access trials. Trial sponsors will now be accountable for diversity targets, and patients should have access to trial services closer to home.

To move these efforts forward, we held a Virtual Day of Action, during which our advocates sent over 1,400 letters to Congress. LLS Board member Ruben Mesa, M.D. testified before a key congressional committee about the importance of trial diversity. In December, advocates met with nearly

100 Congressional offices to highlight the issue–just weeks before the U.S. House and Senate voted the changes into law.

• In-network access to cancer centers for Medicaid patients in New York and California. LLS advocacy was influential in the adoption of a New York law that will designate specialty cancer centers as “in-network” for millions who have health insurance through the marketplace or Medicaid. Our efforts also helped to drive passage of the California Cancer Care Equity Act, which gives the 13 million Californians covered by Medicaid access to specialty cancer centers, even if they’re not in-network. Both laws enhanced coverage through Medicaid which serves patients with lower incomes, and in both states, most patients covered by Medicaid are people of color.

HEALTH EQUITY BY THE NUMBERS

More than $1.3 MILLION committed by LLS to enhance understanding of disparities in blood cancer care

More than 100,000 individuals with blood cancer reached

by LLS’ inaugural Latino outreach efforts in California

Only 5-8% of blood cancer patients currently enroll in clinical trials; percentages even lower for underserved populations

79% bone marrow matching rate for Caucasian patients; 48% for Hispanics/Latinos; 47% for Asians; 29% for Blacks*

SIX MEDICAL CENTERS using LLS IMPACT grants to expand availability of clinical trials, up from three in 2021

More than 1,400 letters sent to Congress by LLS advocates on our Virtual Day of Action: 381 members of Congress reached

*Source: Be The Match

For more data on how LLS is driving forward health equity, scan here

MICAH

ALL survivor

12 | The Leukemia & Lymphoma Society

Patient Financial Assistance The ever-rising cost of blood cancer care has left patients and families bearing the financial burden. LLS believes no patient should be denied treatment because they cannot afford it.

Our financial assistance programs help overcome financial barriers so that patients can access the right care at the right time. This year, we significantly boosted our grants, providing more than $385 million in awards to more than 75,000 patients, up from $241 million to more than 42,000 patients last year.

NEW IN 2022

MEET

Munira Nuru

LLS Helps Student’s Dream Come True The daughter of Ethiopian immigrants, Munira Nuru of Lees Summit, MO, has long possessed a special determination to succeed—a quality she attributes to her family’s unique history. Growing up in Addis Ababa, her parents were taught to value hard work and accomplishment, but were unable to attend college. During her own childhood, Munira’s parents “never failed to instill the value of education,” yet she knew money was tight. To reduce college costs, she took AP and dual-credit classes during high school.

But a diagnosis of acute lymphoblastic leukemia (ALL) threw a curveball into her plans. “My concerns switched from trying to spare my parents the overwhelming cost of college to watching them struggle to pay for the medicine I needed to survive,” she said. Although Munira began her bachelor’s degree in biology at a low-cost community college, tuition became challenging when, after two years, she transferred to the University of Missouri, Kansas City. As a recipient of The Leukemia & Lymphoma Society’s Scholarship for Blood Cancer Survivors, she can now continue to pursue the degree she is “passionate about”—happy to show her parents that “all they taught me about hard work, grit, and the value of knowledge has finally paid off.”

LLS Scholarship for Blood Cancer Survivors We are helping young survivors achieve their educational goals, offering scholarships up to $7,500 for one year of higher education tuition. The 100 inaugural recipients spanned 34 states. Nearly one-fifth are first generation college students, and nearly half are studying science, health science, and nursing. Every year, we plan to award new recipients and renew eligible past awardees.

Financial Relief for Patients Impacted by Hurricanes Fiona & Ian In the wake of the destruction caused by Hurricane Fiona and Hurricane Ian, LLS opened the LLS Financial Relief Fund to help blood cancer patients impacted by the storms in the FEMA designated disaster areas. Blood cancer patients living in declared disaster areas due to Hurricanes Fiona and Ian were eligible to receive a $250 pre-paid VISA card to help offset day-to-day expenses like food, clothing, housing, and gas.

2022 Annual Report | 13

“

One of the worst side-effects of fighting cancer is the cost of care. We are taking bold action to ensure that patients are not the only ones shouldering the rising cost of cancer care.

”

— Louis J. DeGennaro, PhD, LLS President and CEO

Making Treatments More Affordable for Patient and Families 2022 ASSISTANCE FROM OUR SIGNATURE PROGRAMS

Co-Pay Assistance Program Helps cover costs for prescription drug insurance, plan premiums and co-pay obligations for specific diseases.

Urgent Need Programs Assists patients in acute financial distress with $500 for non-medical costs. In partnership with Moppie’s Love, Charlie’s Fund, and other generous donors.

Patient Aid Program Provides a one-time stipend of $100 for any blood cancer patient with non-medical expenses.

Patient Travel Assistance Programs Helps cover treatment-related transportation and lodging costs. Susan Lang Pay-It-Forward: $500 available every six months. Pre CAR-T-cell Therapy: $2,500 for patients under evaluation for CAR T-cell therapy. New: Multiple Myeloma Fund and the Pediatric Travel Fund.

14 | The Leukemia & Lymphoma Society

Scan here to see more in-depth information including ethnic, economic, and geographic data.

$371.5M

36,849

$5.8M

11,763

$1.5M

15,405

$6.5M

11,486

IN ASSISTANCE

IN ASSISTANCE

IN ASSISTANCE

IN ASSISTANCE

PATIENTS

PATIENTS

PATIENTS

PATIENTS

Education and Wellness LLS is proud to be the leading “go to” source of free information and support for blood cancer patients, families, caregivers, and healthcare professionals. With an extensive array of services and materials, LLS provides essential guidance along the way from diagnosis, treatment to survivorship. This year, we increased outreach and support and expanded our innovative offerings.

NEW IN 2022

Nearly 1,000 volunteers dedicated more than 26,000 hours to help LLS with outreach, information, and support for patients, families, and healthcare providers.

Extended Nutrition Service and Resources LLS’s proprietary one-on-one oncology nutrition consultation service added a second registered dietician, allowing us to serve over 1,000 patients and caregivers throughout the year.

New resources include printed and online materials for patients and healthcare professionals to raise awareness of patient food insecurity and provide referral resources, and the first in an innovative series of online nutrition-education videos for pediatric cancer families.

“

Patients and their families often experience uncertainty and challenges, from diagnosis through survivorship. LLS is here to answer questions, address concerns, provide support, and foster hope.

— Elisa Weiss, PhD, LLS Senior Vice President, Education, Services, & Health Research

”

Expanded Survivorship Support To better serve those who have completed treatment, we issued numerous podcast episodes. A Conversation on Adult Survivorship, for healthcare professionals, had nearly 4,500 listens. Moreover, we released an online and print LLS Survivorship Workbook, used by over 13,000 individuals. LLS Community, an online social network, created a new “Ask the Expert” series which reached almost 20,000 people and won a Bronze Award in the Spring 2022 Digital Health Awards.

2022 Annual Report | 15

Educating And Connecting Patients, Families, And Providers

Scan here to find more data on the reach of our education and support services.

OUR FREE SIGNATURE SERIVCES

Information Resource Center One-on-one information and support from highly trained oncology social workers and nurses.

Clinical Trial Support Center Individualized assistance from nurse navigators to help patients enroll in trials.

Patient and Healthcare Professional Education

APPROXIMATELY

26K

Myeloma Link

MORE THAN

LLS Community

MORE THAN

PATIENTS ASSISTED

Educational events featuring experts covering treatment options, breakthroughs, and survivorship issues.

INDIVIDUALS HAVE JOINED

SPECIALIST-PATIENT INTERACTIONS

1K

MORE THAN

500K

Outreach in Black communities to raise awareness and help patients access leading-edge care and resources.

Blood Cancer Conferences

Education and resources BOOKLETS/FACT for patients, caregivers, and SHEETS DOWNLOADED healthcare professionals.

OR ORDERED

Online community to chat, share experiences and provide support.

Patti Robinson Kaufmann First Connection® Program

Personalized Nutrition Consultations

Peer-to-peer support that matches patients and caregivers with trained volunteers who experienced blood cancer.

MORE THAN

2K

PEER-TO-PEER CONNECTIONS MADE

MEET

NEARLY

22K

PEOPLE REACHED

19K 12

CONFERENCES, REACHING 6,485 ATTENDEES

MORE THAN

1K

One-on-one sessions with registered dietitians with oncology expertise to help PATIENTS/CAREGIVERS improve nutrition and manage RECEIVED A NUTRITION treatment side effects.

CONSULTATION

Tim Heberlein

Father’s Passion Helps Others Realize Their Dreams

16 | The Leukemia & Lymphoma Society

Nothing is more important to a parent than their children's health.

In August, 2019, Tim Heberlein of Tampa received word that his two-year old son, Remy, had Pre-B-cell acute lymphocytic leukemia (ALL).

A tough three-year treatment journey ensued, including numerous rounds of

Access to Better, More Affordable Care For decades, LLS has advocated by raising the voices of blood cancer patients and their families. At the heart of our efforts is a nationwide grassroots network of more than 200 volunteer advocacy leaders and 30,000 active online volunteers working hard to effect change. Together, we’ve made a tremendous impact.

200

VOLUNTEER ADVOCACY LEADERS WORKING IN THEIR STATE CAPITALS AND IN WASHINGTON, D.C.

New in 2022 Landmark Medicare Law Limits Patients’ Costs For nearly a decade, LLS has urged lawmakers to limit outof-pocket drug costs for patients covered by Medicare, since many of those patients spend more than $10,000 a year on treatment. This year, LLS helped pass a transformative law that will cap Medicare beneficiaries’ out-of-pocket prescription drug costs at $2,000 annually. This will transform—and save—lives.

Making Health Insurance Work for Patients LLS-commissioned research has highlighted the critical role robust provider networks play in assuring patients’ access to timely care. This year, we helped secure a new federal rule requiring insurers to improve provider networks for plans sold through Healthcare.gov and other Affordable Care Act marketplaces. We also aided passage of a new federal policy requiring insurers to offer standardized health plans, including more affordable drug coverage, in the Affordable Care Act marketplaces. And thanks in part to our advocacy, millions of U.S. patients will now enjoy low- or no-cost health insurance premiums for coverage purchased through Healthcare.gov through at least 2025.

30,000

ACTIVE ONLINE VOLUNTEER ADVOCATES WORKING TIRELESSLY TO PROTECT PATIENTS

Working to Ensure Affordable Drugs for Minnesotans Thanks to our long-term advocacy, insurance plans will be required to charge an affordable, flat fee for prescription drugs, rather than a percentage of drug costs—a huge savings for those taking expensive specialty drugs. This marks LLS’ third state victory for better insurance coverage of costly drugs in the past three years alone.

Protecting Patients from Surprise Medical Bills We continued our efforts to influence federal regulations pertaining to implementation of the No Surprises Act (NSA), which ends surprise medical billing. Our involvement included filing legal briefs in numerous court cases dealing with attempts to unravel this Act and making sure states consider patient perspectives as they pass laws and rules related to these protections.

Leading Efforts to Put an End to Junk Insurance As a nationwide leader in the battle against “junk” insurance policies (that discriminate against those with cancer and other serious health conditions), we made headway in Kansas, helping to defeat a measure that would have expanded availability of these plans. Additional progress was made in Colorado, where we helped secure a law that will enable regulators to gather more information about these dangerous policies. We continue to advocate for stronger federal protections.

chemotherapy, but thankfully, in October 2022, Remy got to “ring the bell” signaling the end of his treatments. While his son’s treatments have ceased, Tim’s desire to fight for the rights of fellow blood cancer patients remains in full swing. In 2021, in the midst of Remy’s cancer battle, he was appointed the LLS Advocacy Leader in Florida. In this role, he leads a robust committee of advocacy volunteers responsible for helping advance the LLS Office of Public Policy’s (OPP) goals. Tim provides strategic direction, including identification of new advocacy volunteers, and helps develop advocates' skills so they, too, can effectively influence lawmakers to take action on issues critical to the blood cancer community. His invaluable 2022 contributions to LLS included building relationships with his members of Congress and their staff and urging them to take action on specific pediatric policy priorities. Tim accomplished this through visits in the district and virtually in Washington D.C. as part of LLS’s Lobby Day and the Alliance for Childhood Cancer Action Day.

2022 Annual Report | 17

Big Dreams, BOLD PROGRESS

SARAH

ALL survivor

JANIE

lymphoma survivor

HERBIERTO

lymphoma survivor

SHARON

multiple myeloma survivor

HUDSON

ALL survivor

SIMANTINEE

lymphoma survivor

Passionate Philanthropy Making An Impact A “Village” Of Dreamers Helps Advance Our Mission If it sometimes takes a village to achieve one’s goals, LLS is fortunate to have such a community: the thousands of volunteers, donors, and corporate partners that, each year, help us raise the funds we need to conquer blood cancer.

In 2022, receding COVID-19 restrictions allowed us to begin transitioning back to in-person fundraising events, with great success. Participants across the globe crossed long-awaited finish lines, hit the slopes, hiked to new heights, and participated in virtual challenges…setting records in the process. The following LLS “village superstars” represent but a sampling of our dedicated supporters.

Adam Neary: National Man of the Year (MOTY)

Emily Lipman Mahar: National Woman of the Year (WOTY)

A Principal at WealthOne, LLC, Adam of Albany, NY, competed for LLS National MOTY, aiming for the highest total raised over a 10-week campaign. His mission was accomplished, bringing in $1,095,692 to support LLS. Adam’s participation was in honor of his friend and mentor, Todd Slingerland, who was diagnosed with an aggressive lymphoma in spring 2021. While Todd fortunately reached remission after several months of treatment, Adam’s drive was unabated. “Todd is a survivor today because of the investment, research, and support for which LLS tirelessly champions,” he said.

“Just because Todd’s cancer is dormant, doesn't mean we can be— the fight continues, until we find a cure.”

After losing her mother, Eva Goldberg Lipman, to Hepatosplenic Gamma Delta T-cell lymphoma, a rare form of lymphoma in November 2020, Emily, owner of Emily Lipman Designs in Atlanta, turned her pain into passion by running for National WOTY. “I accepted this nomination knowing it would be difficult, but also I knew this was the way to honor my mother,” she said. “[My mother] gave back in so many ways, and now it was my turn.

No family should have to experience the devastation of cancer.”

Lipman Mahar’s record-setting $1,001,911 raised made her the first National WOTY to raise over $1 million in the campaign’s over 30-year history.

18 | The Leukemia & Lymphoma Society

Jordan Loughran, Alice Voigt, and Barrett Hight: Students of the Year (SOY) Three Atlanta high school juniors, all touched by blood cancer, formed “The Answer for Cancer” fundraising team. Leveraging their own musical talents to create an inspiring song video with over 1,000 YouTube views, they raised $559,366 for LLS— a record for the LLS Georgia-South Carolina Region. “As I got older, I became aware of the massive impact LLS's funding played in my cancer journey,” said Loughran, a 13-year leukemia survivor. Hight (18) participated to honor Loughran, and his grandmother, a non-Hodgkin lymphoma patient. And Voight (17) lent her singing voice in tribute to her cousin, Garland, diagnosed with Hodgkin lymphoma. “Why should our age limit us in galvanizing together with our communities so that one day, nobody has to hear the word ‘cancer’?” Voight said.

Dr. Marvin Connelly: Light The Night (LTN) After learning he had cancer in February 2019, Marvin was “ready to battle and fight hard.” This Fayetteville, NC school superintendent and pastor took inspiration from Layla Smith, a second grade blood cancer survivor at one of his schools. “Her story encouraged me along my journey and is part of the ‘WHY’ I wanted to be involved with LLS,” he said. Fighting for “many more Laylas,” Marvin helped his district raise over $100,000 for LLS in the last two years, including $70K in FY22— with plans to raise an additional $60K for his 60th Birthday. Along with a group of district staff and students, Marvin attended his first in-person LTN event in Raleigh in October, honoring Layla. He called it “an amazing event… one of the highlights of my lifetime.”

John Reumann: Team In Training

Gentile Family: Big Climb

Before learning of his own Chronic Lymphocytic Leukemia (CLL) diagnosis in 2013, John, an avid cyclist, marketing vice president, and current Chairman of the Board of Trustees for the Rocky Mountain Region, had participated in events that raised money for “virtually every charitable cause.” Once diagnosed, he joined LLS Team in Training (TNT) and formed Team Survivor, raising over $750,000 to LLS research. In his 2022 ride, his 9th, the Denver area resident journeyed with his team to Lake Tahoe and raised $125,000 to provide funding for a research portfolio—earning an LLS Impact Award in the process.

“I will continue to ride for my friends who are in treatment and for those we have lost to this disease,” he stated, pledging he will “try to ride faster than Leukemia.”

In the summer of 2021, David and Heather Gentile of Haddon Twp, NJ, grew concerned over their two-year-old daughter Grace’s health. Multiple infections and uncharacteristically low energy led to various pediatrician appointments, a visit to the local ER, and a transfer to Philadelphia Children’s Hospital where doctors diagnosed B Cell Acute Lymphocytic Leukemia (ALL). Months of grueling treatments followed, including intensive chemotherapy, but by May 2022, Grace was placed on a maintenance treatment.

That same month, the Gentile family participated in Big Climb Philadelphia, as part of the corporate team formed by David’s employer, Admiral Insurance—raising $13,740 for LLS’ mission.

Despite “bumps in the road,” David relayed that Grace, now in preschool, “continues to thrive, plays tots soccer, and has hopes of being a mermaid doctor when she grows up.”

2022 Annual Report | 19

YOUR GENEROSITY AT WORK Achievements Include: Campaigns continue to grow, raising more than $172M Direct to Consumer Campaigns grew by 11% raising nearly $45M Advancement colleagues connected with donors in new ways, raising $66.2M “Of the Year” mobilized community leaders and next-generation philanthropists to new revenue heights—with top fundraisers raising more than $1M Light The Night was recognized as the number three peer-to-peer fundraising program in North America Thousands of Team In Training teammates came together for athletic events across the country raising more than $16M. Virtual event offerings continued to grow through the Resilience Challenge and Bike for Breakthroughs.

2022 VOLUNTEER CAMPAIGN HONOR ROLL Light The Night: Bryan Clementson, San Diego, CA, raised $250K+ Team in Training: Andrea Ferenchik, Cumming, GA, raised $171K+ National Man of the Year: Adam Neary, Albany, NY, raised $1.095M National Woman of the Year: Emily Lipman Mahar, Atlanta, GA, raised $1M National Visionary of the Year: Deborah Sturges, Fort Wayne, IN, raised $302K National Man of the Year Runner-up: David Borowski, Ashburn, VA, raised $595K National Woman of the Year Runner-up: Natasha del Barrio, Rio Grande Valley, TX, raised $840K National Visionary of the Year Runner-Up: Richard Schwartz, Los Angeles, CA, raised $196K National “All Star” Man of the Year: Matt Newsom, Charlotte, NC, raised $539K

DONORS

Dream Along with Us Jim Beck, Pennsylvania

“

My brother Bobby died of leukemia on Christmas Day in 1951 at the age of 4, before I was born. For more than 40 years, my family and I have contributed to LLS, and by far the most meaningful impact we have made is through our support of LLS’s new book trilogy for pediatric patients and their families, entitled The Stars Will Twinkle, The Sun Will Shine.

My older brother Johnny was 7 when Bobby died; when Johnny read the trilogy, he said that having this resource would have made a world of difference for him and our family.”

Amy Lee, Texas

“

As a current survivor of stage IV aggressive diffuse large b-cell non-Hodgkin lymphoma, I know firsthand how important it is to support LLS’s efforts.

In fact, one of my curative measures was funded

by LLS. Our family is honored to support Student Visionaries of the Year, Light the Night, and the Dare to Dream Project.

I am not in control of the cancer coming back, but I AM in control of being positive, having faith over fear and making it my lifelong mission to give back and to support those who receive a cancer diagnosis.”

National “All Star” Woman of the Year: Christine Mills, Washington, D.C., raised $133K National “All Star” Visionary of the Year: Liz Sczudlo, Los Angeles, CA, raised $195K National 2022 Students of the Year winners: “The Answer for Cancer”, Jordan Loughran, 18, Barrett Hight, 18, Alice Voigt, 17, Pace Academy, Atlanta, GA, raised $559K 2022 National Students of the Year runners-up: “Team Mission to Remission”, Katelyn Eberwein, 17, Charley Schumacher, 17, Sydney Yee, 17, Bishop Gorman High School, Las Vegas, NV, raised $537K

20 | The Leukemia & Lymphoma Society

CORPORATE PARTNERS ALIGNED WITH OUR MISSION

Many thanks to these companies who held steadfast in their commitment to LLS:

Please visit www.LLS.org/AnnualReport to read our full Fiscal Year 2022 Annual Report, including acknowledgments.

Pablo Legorreta, Chief Executive Officer, Royalty Pharma, New York

Thank You

“

Despite many advances in blood cancer care and treatment, barriers exist in many communities to prevent patients from accessing new, more effective therapies and protocols that can lead to better outcomes. The gift awarded through Royalty Pharma’s alliance with The Leukemia & Lymphoma Society is intended to propel the work LLS is doing in underserved communities through three key initiatives that will help break down these barriers and ensure that everyone has access to the care they need to treat their blood cancer.”

As always, LLS gratefully thanks all of our dedicated volunteers and donors who help make our lifesaving work possible. Whether raising critical funds, advocating for lifesaving policies, providing support to those impacted by cancer, or building critical capacity, our donors, volunteers and supporters are invaluable as we continue to advance the LLS mission.

The Harry T. Mangurian, Jr. Foundation, Florida

“

Greg and Marcie Sinaiko, California

“

My wife Marcie and I first got involved with LLS following my diagnosis with Hodgkins lymphoma in 2017. I needed a stem cell transplant and was referred to the Information Resource Center for information on how to proceed with the treatment. Following my treatment and ultimate recovery, my entire family became very involved with LLS. I joined the Greater Los Angeles Board in 2019, where I currently serve as Board Chair. Our middle daughter, Samantha, was a Student of the Year candidate in 2021, our youngest daughter is on a team in 2022, and Marcie has been on the Visionary of the Year committee. Our family has gathered a large group of team participants for the past two Light the Nights and we have generously supported innovative research led by LLS in the pursuit of an ultimate cure for Hodgkins lymphoma.”

AbbVie Inc.

Eli Lilly and Company

Amgen Inc.

Gateway for Cancer Research

BeiGene, Ltd. Bristol Myers Squibb Burlington

Since its inception in 1999, The Harry T. Mangurian, Jr. Foundation has built an ongoing partnership with The Leukemia & Lymphoma Society. While leukemia claimed the life of our founder, his legacy has lived on through the Foundation’s participation in the Beat AML Master Clinical Trial and the Children’s Initiative. Further, throughout our relationship, the transparency and stewardship provided by LLS to all of its supporters through interim and annual reporting has shown that exceptional progress has been realized through research, clinical trials and, most importantly, the saving of lives. We are proud to be a part of the team leading the fight to eradicate this disease.”

GSK (formerly known as GlaxoSmithKline) Janssen Biotech

Genentech Inc.

Jazz Pharmaceuticals

Gilead Sciences, Inc.

Kite, A Gilead Company

Pfizer Inc.

Subaru of America Inc.

Pharmacyclics, An AbbVie Company & Janssen Biotech

Takeda Oncology

Royalty Pharma

Walgreens Wawa

2022 Annual Report | 21

Big Dreams, BOLD PROGRESS

Dream Continues...

THE

2022 was a year of important transformation and significant milestones for LLS. We celebrate our achievements, but our work goes on and our dreams continue.

We will continue to pursue bold progress across all our mission priorities, until we realize our mission’s end goal: a world without blood cancers.

Our priorities include…

Outsmarting Cancer Through Research One of the world’s leading funders and authorities on blood cancer research, LLS has contributed to nearly every new treatment in recent decades.

Advancing Health Equity LLS is committed to making sure ALL blood cancer patients have access to and receive the treatment they need, regardless of location, race, language, or income.

Supporting Survivors LLS recognizes blood cancer patients have a lifelong journey to navigate and we are here for them, from diagnosis and treatment, through remission and beyond.

Patient Financial Assistance LLS is committed to relieving the financial burdens felt by patients who are coping with blood cancer through our Patient Financial Assistance Programs.

22 | The Leukemia & Lymphoma Society

Improving Access to Clinical Trials LLS is dedicated to helping patients access clinical trials to improve the care and treatment they receive for their specific blood cancer.

Access, Quality and Affordability of Care To give them their best chance for a cure and long-term quality of life, LLS is continually advocating to ensure all patients receive the best healthcare available.

Education & Wellness Every step of the way, LLS is the leader in free information and comprehensive support for blood cancer patients, families, and healthcare professionals.

Dare To Dream Project With The Dare to Dream Project, LLS is ushering in a new era of pediatric research, treatment, and care for children with cancer.

2022 Annual Report | 23

Big Dreams, BOLD PROGRESS

ROGER

lymphoma survivor

JELIEN

ALL survivor

GWENDOLYN

multiple myeloma survivor

JOSE

CML survivor

SHUSHAN

Hodgkin lymphoma survivor

TERSESA

CLL survivor

Your Support is Invested Wisely In fiscal year 2022, LLS raised $444 million to support our mission and operations.

We spent $434 million—or 81% of our expenses—on specific programs designed to find new treatments for blood cancers, provide financial asssistance to blood cancer patients, break down barriers to care, and improve the lives of patients and their families.

Operations Makes the Mission Possible! Operational costs fuel the various ways LLS supports patients and families: from the free personalized assistance offered in our Information Resource Center and Clinical Trial Support Center; to podcasts, chats and opportunities to connect with others in our online community; to Virtual Blood Cancer Conferences staffed with experts in the field.

CONSOLIDATED STATEMENT OF ACTIVITIES For the year ended June 30, 2022 (USD Thousands)

CONSOLIDATED BALANCE SHEET

Revenue

Assets

Campaign contributions

$

Less: direct donor benefit costs

Cash and cash equivalents

(15,474)

Prepaid expenses and other assets Contributions and other receivables, net

25,382

Investments

402,862

Investments held for Co-Pay program

250,026

269,349

Co-Pay contributions

$

129,256

Royalties and other income

37,055

Net interest and dividend income

8,204 443,864

Operating Expenses $

94,190

Patient and Community Service

304,208

Public Health Education

22,899

Professional Education

12,444

Total Program Services

$

Total assets

10,996 5,861

Fixed assets, net

10,915 $ 706,042

Liabilities Accounts payable and accrued expenses

Program Services Research

9% Fundraising

284,823

$

$

& General

As of June 30, 2022 (USD Thousands)

Net campaign contributions

Total revenue

P rogram 81% Services 10% M anagement

$

25,729

Deferred revenue

14,134

Awards and grants payable

50,225

Co-Pay assistance payable

229,195

Other long-term liabilities

4,570

Total liabilities

$ 323,853

$

433,741

$

54,039

Without donor restriction

46,457

With donor restriction

$

100,496

Total net assets

$

Total operating expenses

$

534,237

Total liabilities and net assets

$ 706,042

Foreign currency loss

$

Supporting Services Management and general

Net assets

Fundraising Total Supporting Services

Net Increase in fair value of investments Change in net assets

24 | The Leukemia & Lymphoma Society

(478) (51,949)

$ (142,800)

$

316,414 185,183 382,189

OUR

Giving Promise

AT LLS, WE BELIEVE...

GIVING IS PERSONAL. Contributions don’t come from the wallet—they come from the heart. We respect how deeply our donors feel about what we do and why we do it.

GIVING IS COMMUNITY. A shared passion for change unites us.

No matter where we live or who we are, we are together as one for a common cause.

GIVING IS GOOD. Our donors believe in sharing their resources willingly for the good of all, not just themselves.

GIVING IS HONEST. We are always open about how, why, where, and when we use your contributions.

GIVING IS IMPACT. We strive to make a meaningful difference in the lives of those around us and for those we may never meet.

THANK YOU FOR GIVING. Your generosity makes our work possible, and we promise to uphold your trust in us.

2022 Annual Report | 25

YOUR

Generosity

helps LLS do great work and it's getting noticed

LLS is proud to be recognized as a Fast Company 2022 Brand That Matters. LLS is the only cancer organization on the list and the only healthcare organization in the not-for-profit category.

LLS has a Four-Star Rating from Charity Navigator, America’s largest independent charity evaluator. This rating designates LLS as an official “Give with Confidence” charity, indicating that our organization is using its donations effectively.

3 International Drive, Suite 200, Rye Brook, NY 10573 • 914.949.5213 The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org.

P001-2022 1/23

SUPPORTING

ZARIYAH

ROBERT

ALL survivor

Hodgkin lymphoma survivor

ARYANNA

ROY

multiple myeloma survivor

non-Hodgkin lymphoma survivor

Patient Aid Program LLS is dedicated to alleviating the burdens felt by patients coping with blood cancer.

We work to ensure that patients are aware of all the services LLS has to offer and that no one is denied treatment because they cannot afford it. The LLS Patient Aid Program provides a one-time stipend of $100 to help offset expenses; there is no income criteria to qualify for the program.

More than

More than

Nearly

patients assisted

in assistance awarded

referred by a healthcare professional or facility

15,400

$1.5M

61%

Patient Aid Program awarded assistance to...

PATIENTS IN

63%

OF ALL U.S. COUNTIES

OF THE MOST RURAL COUNTIES**

ZEENA

ALL survivor

Hodgkin lymphoma survivor

“

I live in Osprey, Florida and make frequent trips to Tampa. This is 90 minutes from our home. Needless to say, especially with the price of gas as it is right now, it is costly to make that drive back and forth. The $100 check I received will be used to offset the cost of gas. It has been very helpful and has made this difficult journey easier to navigate.

— Karen, Patient

”

PATIENTS IN

PATIENTS IN

30%

CHARLES

Patients

55%

OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES*

More than 60% of recipients have accessed other LLS financial assistance programs

More than 13% were unemployed or retired

Of all the veterans assisted during FY22, 44% received Patient Aid awards

Patient Aid Assistance, by Race, as Identified by Patient

66%

White

20%

Black / African American

6%

Other

4%

Prefer not to disclose

2%

Asian

1%

American Indian / Native Alaskan

<1%

Native Hawaiian / Pacific Islander Patient Aid recipients as Hispanic / Latino 13% ofidentified

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org. *Based upon USDA Economic Research Center 2020 data. **Based upon USDA RUCC scale.

1/23

SUPPORTING

ZARIYAH

ROBERT

ALL survivor

Hodgkin lymphoma survivor

ARYANNA

ROY

multiple myeloma survivor

non-Hodgkin lymphoma survivor

CHARLES

Patients

ZEENA

ALL survivor

Hodgkin lymphoma survivor

Pediatric, Adolescent and Young Adult

Urgent Need Program When it comes to coping with blood cancer treatment, children, adolescents and their families and caregivers have a wide range of unique needs and challenges, which are unlike those of adults.

The Urgent Need Pediatric, Adolescent and Young Adult Program, in partnership with Moppie’s Love, provides $500 in financial assistance to patients in acute financial need. The award covers non-medical expenses including housing, food, utilities, child/elder care, and other essentials.

More than

More than

total patients assisted

in assistance awarded

$1.8M

3,700

More than 69% of families report an annual income of $40,000 or less

Urgent Need Program, Pediatric, Adolescent and Young Adult awarded assistance to...

PATIENTS IN

34%

OF ALL U.S. COUNTIES

PATIENTS, OF WHOM

19%

RESIDED IN MEDICALLY UNDERSERVED AREAS*

Families report struggling with food, rent, mortgage, and bills for electricity and heat

46% of cancer patients reduced spending on food and clothing†

Age Breakdown

18%

Pediatric

(0-14 years old)

8%

Adolescent

(15-19 years old)

PATIENTS IN

30%

OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES**

More than 81% of recipients have accessed other LLS financial assistance programs

74%

Young Adult

(20-39 years old)

“

I wanted to reach out and say thank you so much for helping our family during this time! This has been such a hard time on us emotionally & financially. Since Jocelyn was diagnosed, I have not been able to work. With all the endless appointments and stress of just keeping it “together” for the family, going back to work brings me anxiety…

I just wanted to say thank you so so much for helping our family financially during this time when inflation is out of hand. You are greatly appreciated!

”

— Andrea, Jocelyn’s Mother

Urgent Need Program, Pediatric, Adolescent and Young Adult Assistance,

by Race, as Identified by Patient

58%

White

22%

Black / African American

9%

Other

6%

Prefer not to disclose

3%

Asian

1%

American Indian / Native Alaskan

<1%

Native Hawaiian / Pacific Islander

Urgent Need recipients as Hispanic / Latino 22% ofidentified

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org. *Based on designation by HHS’s Health Resources and Service Administration. **Based upon USDA Economic Research Center 2020 data. †“Zafar, The Oncologist, 2013.”

1/23

SUPPORTING

ZARIYAH

ROBERT

ALL survivor

Hodgkin lymphoma survivor

ARYANNA

ROY

non-Hodgkin lymphoma survivor

multiple myeloma survivor

CHARLES

Patients

ZEENA

ALL survivor

Hodgkin lymphoma survivor

Adult

Urgent Need Program LLS is determined to break down barriers and help address the dilemma patients face when having to choose between paying for treatment or paying for their day-to-day living expenses.

The Urgent Need Adult Program, in partnership with Charlie’s Fund, provides $500 in assistance to offset non-medical expenses including housing, food, utilities, child/elder care, etc.

8,050

total patients assisted

More than

$4.0M

in assistance awarded

More than 70% of recipients report an annual income of $40,000 or less

Urgent Need Program, Adult awarded assistance to...

PATIENTS IN

49%

OF ALL U.S. COUNTIES

PATIENTS, OF WHOM

19%

RESIDED IN MEDICALLY UNDERSERVED AREAS*

More than 51% were unemployed or disabled More than 84% of recipients have accessed other LLS financial assistance programs

PATIENTS IN

45%

OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES**

Reported need:

23% U tilities (including gas, electric, heat; excluding cable, internet)

20% Housing (mortgage/rent) 19% Transportation

“

I was not able to work and had almost no income during this time... LLS responded very quickly, sending us financial assistance through their Urgent Need Program. This assistance helped pay a propane heating invoice during a critical period in late winter. Cancer can be very difficult, but the financial assistance we received from LLS helped alleviate some of the financial stress that can accompany Lymphoma/ Leukemia treatments. We are very thankful for your help.

— Robert, Patient

”

Urgent Need Program, Adult Assistance,

by Race, as Identified by Patient

64%

White

25%

Black / African American

4%

Other

5%

Prefer not to disclose

2%

Asian

1%

American Indian / Native Alaskan

<1%

Native Hawaiian / Pacific Islander Urgent Need Adult recipients as Hispanic / Latino 9% ofidentified

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org. *Based on designation by HHS’s Health Resources and Service Administration. **Based upon USDA Economic Research Center 2020 data.

1/23

SUPPORTING

ZARIYAH

ROBERT

ALL survivor

Hodgkin lymphoma survivor

ROY

ARYANNA

multiple myeloma survivor

non-Hodgkin lymphoma survivor

CHARLES

Patients

ZEENA

ALL survivor

Hodgkin lymphoma survivor

Susan Lang Pay-It-Forward

Travel Assistance Program Regardless of where patients live, transportation barriers are often cited as an obstacle to accessing care. Through the Susan Lang Pay-It-Forward Travel Assistance program, LLS provides financial assistance of $500 to help with treatment-related transportation and lodging.

More than

More than

total patients assisted

in assistance awarded

11,050

$5.5M

More than 66% of recipients report an annual income of $40,000 or less

“

Without this assistance there is no way I could have afforded filling my gas tank and my son’s (he drove me to the majority of my appointments when I wasn’t able). Thank you so much LLS, fighting cancer becomes much easier when not fighting gas prices and poverty.

— Scott, Patient

Susan Lang Pay-It-Forward Travel Assistance Program awarded assistance to...

PATIENTS IN MORE THAN

53%

OF ALL U.S. COUNTIES

PATIENTS, OF WHOM

19%

RESIDED IN MEDICALLY UNDERSERVED AREAS*

More than 93% of recipients have accessed other LLS financial assistance programs

PATIENTS IN

48%

OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES**

79% of all

patient expenses were fuel related

”

Susan Lang Pay-It-Forward Travel Assistance, by Race, as Identified by Patient

65%

White

23%

Black / African American

5%

Other

3%

Prefer not to disclose

2%

Asian

1%

American Indian / Native Alaskan

<1%

Native Hawaiian / Pacific Islander

10%

of Susan Lang Pay-It-Forward Travel Assistance recipients identified as Hispanic / Latino

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org. *Based on designation by HHS’s Health Resources and Service Administration. **Based upon USDA Economic Research Center 2020 data.

1/23

SUPPORTING

ZARIYAH

ROBERT

ALL survivor

Hodgkin lymphoma survivor

ROY

ARYANNA

multiple myeloma survivor

non-Hodgkin lymphoma survivor

CHARLES

Patients

ZEENA

ALL survivor

Hodgkin lymphoma survivor

Susan Lang Pay-It-Forward

Pre CAR T-Cell Therapy Travel Assistance Program Transportation and lodging are the largest out-of-pocket expense for patients during treatment weeks. LLS is addressing these barriers through its Susan Lang Pre CAR T-cell Therapy Travel Assistance program. The program provides $2,500 to patients who are being evaluated to receive CAR T-cell therapy as either standard treatment or a clinical trial. CAR T-cell therapy is a form of immunotherapy that uses specially altered T cells. The assistance covers the cost of treatment-related travel and lodging expenses for the patient and caregiver.

Pre CAR T-Cell Therapy Travel Assistance Program awarded assistance to...

MORE THAN

420

TOTAL PATIENTS ASSISTED

MORE THAN

$1.0M

IN ASSISTANCE AWARDED

More than 83% were disabled, retired, or unemployed Nearly 62% referred by a healthcare professional or facility

15% were being evaluated

to participate in a Pre CAR T-cell therapy clinical trial

21%

OF PATIENTS ASSISTED RESIDED IN MEDICALLY UNDERSERVED AREAS*

24% of all

patient expenses were for lodging More than 75%

of recipients have accessed other LLS financial assistance programs

“

I live over an hour from the hospital, so the funds given to us by LLS will pay for rent for an apartment for one month, and the groceries and gas we will need to use while living away from our home. The funds provided will also allow for family to drive my two young children to and from the apartment to visit. Without the assistance program my husband and I would be unable to afford the necessary housing for this treatment to move forward.

— ReNita, Patient

”

Pre CAR T-Cell Therapy Travel Assistance,

By Race, As Identified By Patient

74%

White

13%

Black / African American

6%

Other

4%

Prefer not to disclose

2%

Asian

1%

American Indian / Native Alaskan

<1%

Native Hawaiian / Pacific Islander

13%

of Pre Car T-Cell Therapy Travel Assistance recipients identified as Hispanic / Latino

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org. *Based upon USDA RUCC scale.

1/23

SUPPORTING

ZARIYAH

ROBERT

ALL survivor

Hodgkin lymphoma survivor

ARYANNA

ROY

multiple myeloma survivor

non-Hodgkin lymphoma survivor

Co-Pay Assistance Program At The Leukemia & Lymphoma Society (LLS), we are dedicated to alleviating the burdens felt by patients coping with blood cancer and we work to ensure that nobody is denied treatment because they cannot afford it. Our Co-Pay Program assists patients with the financial burden of treatment by paying for medical insurance premiums, treatment-related co-pays, deductibles, co-insurance, and prescription medication related to prescribed treatment.

More than

More than

total patients assisted

in assistance awarded

More than 51% of recipients report an annual income of $40,000 or less

$371M

36,840

77%

OF ALL U.S. COUNTIES

PATIENTS IN MORE THAN

52%

OF THE MOST RURAL COUNTIES IN THE U.S.*

More than 380,000 patient claims paid More than 175,000 calls received from patients, averaging 14,580 calls/month

ZEENA

ALL survivor

Hodgkin lymphoma survivor

“

LLS has helped me with my medical bills. At the time of my diagnosis I was in my last year as a special needs teacher assistant...

I transitioned to Medicare.

Medicare can be expensive when you’re on medication that is not offered in generic form. The assistance I get from LLS is so appreciated.

I am so grateful. Thank you.

— Nancy, Patient

Co-Pay Assistance Program awarded assistance to...

PATIENTS IN MORE THAN

CHARLES

Patients

PATIENTS IN

67%

OF THE COUNTIES ACROSS THE U.S. WITH THE HIGHEST POVERTY RATES**

19% of patients resided in

medically underserved areas† Over 44% referred by a healthcare professional or facility and 25% referred by a pharmacy

”

Co-Pay Assistance, by Race, as Identified by Patient

65%

White

19%

Prefer not to disclose

11%

Black / African American

3%

Other

1%

Asian

<1%

American Indian / Native Alaskan

<1%

Native Hawaiian / Pacific Islander Co-Pay recipients as Hispanic / Latino 9% ofidentified

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org. *Based upon USDA RUCC scale. **Based upon USDA Economic Research Center 2020 data. †Based on designation by HHS’s Health Resources and Service Administration

1/23

SUPPORTING

ZARIYAH

ALL survivor

ROBERT

Hodgkin lymphoma survivor

ARYANNA

ROY

multiple myeloma survivor

non-Hodgkin lymphoma survivor

CHARLES

Patients

ZEENA

ALL survivor

Hodgkin lymphoma survivor

Patient Financial Assistance

By Region

Total Patients Assisted

Total Financial Assistance Awarded

Total Patients Assisted

Total Financial Assistance Awarded

Central Valley

1,146

$5,551,300

Mountain

2,069

$11,006,300

Connecticut - Hudson Valley

1,493

$9,009,000

New England

2,328

$12,758,600

Desert

2,622

$12,593,500

New Jersey

2,158

$12,522,300

Eastern Great Lakes

6,486

$29,235,300

North Carolina - Virginia

4,840

$23,907,600

Eastern PA - Delaware

1,719

$9,021,800

North Florida

3,983

$23,530,200

Georgia - South Carolina

4,969

$21,929,400

Northern California

822

$4,283,000

Greater Los Angeles

1,221

$5,483,800

Ohio River Valley

4,564

$16,743,800

Gulf Coast

3,114

$16,949,500

Pacific Northwest

2,219

$12,800,300

Home Office

17

$77,900

Red River

4,283

$21,677,000

Illinois

1,827

$11,598,100

South Central Texas

1,423

$8,026,100

Lower Plains

4,135

$22,662,600

South Florida

2,101

$10,616,800

Metro New York

1,761

$9,065,900

Southern California - Hawaii

1,657

$7,673,500

Michigan - Indiana

3,740

$20,305,400

Tennessee - Alabama

3,773

$19,903,600

Mid-Atlantic

1,321

$6,511,900

Upper Plains

3,712

$20,092,500

Region

Region, Continued

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org.

1/23

SUPPORTING

ZARIYAH

ALL survivor

ROBERT

Hodgkin lymphoma survivor

ROY

ARYANNA

multiple myeloma survivor

non-Hodgkin lymphoma survivor

CHARLES

ALL survivor

Patients

ZEENA

Hodgkin lymphoma survivor

Patient Financial Assistance

By State

Total Patients Assisted

Total Financial Assistance Awarded

State, continued

Total Patients Assisted

Total Financial Assistance Awarded

Total Patients Assisted

Total Financial Assistance Awarded

Alabama

1,233

$6,029,900

Kentucky

1,717

$5,589,000

Ohio

5,679

$21,887,000

Alaska

54

$307,300

Louisiana

1,061

$5,390,500

Oklahoma

883

$4,710,700

Arizona

1,777

$8,180,700

Maine

486

$2,608,400

Oregon

724

$4,166,900

Arkansas

973

$4,580,800

Maryland

1,056

$5,193,700

Pennsylvania

3,793

$18,533,900

California

4,618

$21,495,600

Massachusetts

1,256

$6,718,600

Puerto Rico

140

$706,300

Colorado

1,294

$6,586,300

Michigan

2,186

$14,189,700

Rhode Island

263

$1,499,000

Connecticut

635

$3,895,000

Minnesota

1,486

$8,300,200

South Carolina

1,979

$8,704,700

Delaware

165

$956,200

Mississippi

682

$3,629,700

South Dakota

374

$1,702,700

District of Columbia

55

$139,300

Missouri

1,815

$9,705,800

Tennessee

2,199

$12,249,900

Florida

6,017

$33,813,400

Montana

242

$1,237,800

Texas

5,441

$29,430,700

Georgia

3,291

$14,667,300

Nebraska

540

$3,212,700

Utah

389

$2,585,300

Guam

2

$24,000

Nevada

457

$2,804,800

Vermont

100

$611,700

Hawaii

109

$671,600

New Hampshire

297

$1,781,300

Virgin Islands

15

$53,900

Idaho

346

$1,886,300

New Jersey

1,508

$9,466,000

Virginia

1,378

$8,300,900

Illinois

1,884

$11,716,000

New Mexico

351

$1,686,100

Washington

1,131

$6,523,300

Indiana

1,849

$7,959,000

New York

3,913

$21,980,200

West Virginia

581

$2,269,600

Iowa

702

$4,499,300

North Carolina

3,529

$15,996,300

Wisconsin

1,749

$9,559,500

Kansas

819

$3,784,300

North Dakota

172

$844,500

Wyoming

108

$513,400

State

State, continued

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org.

1/23

Patients

SUPPORTING

ZARIYAH

ALL survivor

ROBERT

Hodgkin lymphoma survivor

ROY

ARYANNA

multiple myeloma survivor

non-Hodgkin lymphoma survivor

CHARLES

ALL survivor

ZEENA

Hodgkin lymphoma survivor

LLS’S FINANCIAL ASSISTANCE PROGRAMS reached patients or caregivers in 82% of U.S. counties

County Reached County Not Reached

“

”

The assistance programs helped my family and I be able to have food and shelter.

— Rebekah, a patient

NEW DIGITAL FLIP BOOK A Caregiver’s Guide to Navigating Childhood and Adolescent Blood Cancers was selected as a Gold Award winner in the Spring 2022 Digital Health Awards®

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org.

1/23

SUPPORTING

Patients

OFFICE OF PUBLIC POLICY What We Accomplished Together in 2022 ADCOVATES SENT MORE THAN

33,900

LETTERS TO LAWMAKERS IN 2022

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org.

1/23

2022 ANNUAL REPORT ACKNOWLEDGMENTS

Big Dreams,

WITH

Gratitude...

We may be dreamers, but we’re not the only ones.

The Leukemia & Lymphoma Society is forever grateful to the donors, volunteers, researchers, healthcare professionals, foundations, partners, sponsors, and philanthropic leaders across the country who stand with us, year after year, to help us Dream Big and Make Bold Progress.

Your ongoing generosity allows us to break new ground in research, patient support, advocacy, and fundraising.

We look forward to your continued partnership as we all dream of achieving.

Table of Contents RESEARCH GRANTS

1

PARTNERSHIPS

6

ADVISORS

6

DONORS

7

TOP CAMPAIGN SUPPORTERS

20

LEGACY CIRCLE

25

LEADERSHIP

26

Big Dreams, BOLD PROGRESS

RESEARCH GRANTS Specialized Center of Research The Specialized Center of Research program funds multidisciplinary research by teams of leading-edge academic investigators that hastens the discovery and development of better treatments for leukemia, lymphoma, and myeloma patients. A center is comprised of at least three independent research programs that are integrated and supported by scientific core laboratories.

Madhav Dhodapkar, MBBS, 2020 Emory University Dr. Madhav Dhodapkar is funded in part by Emory University, Fred Hutchinson Cancer Research Center, and donations from The LIUNA Charitable Foundation.

Timothy Graubert, MD, 2022 Massachusetts General Hospital Helen Heslop, MD, 2019 Baylor College of Medicine Craig Jordan, PhD, 2019 University of Colorado Anschutz Medical Campus Dr. Craig Jordan is jointly funded by the University of Colorado Anschutz Medical Campus and in part by a donation from Ron and Guadalupe Cohn.

Carl June, MD, 2020© Perelman School of Medicine at the University of Pennsylvania Dr. Carl June is funded in part by a donation from the Higgins Family Foundation.

Jonathan Licht, MD, 2020 University of Florida Tak Mak, PhD, 2023* Princess Margaret Cancer Centre, University Health Network Ari Melnick, MD, 2016 Weill Cornell Medicine Dr. Ari Melnick is funded in part

by Weill Cornell Medicine and a donation from the Mahoney family.

Ari Melnick, MD, 2023* Weill Cornell Medicine

Jaehyuk Choi, MD, PhD, 2022 Northwestern University

Keisuke Ito, MD, PhD, 2019 Albert Einstein College of Medicine

Soheil Meshinchi, MD, PhD, 2022© Fred Hutchinson Cancer Research Center

Simona Colla, PhD, 2019 The University of Texas MD Anderson Cancer Center

Stephen Nimer, MD, 2018 University of Miami Dr. Stephen Nimer is funded in part by donations from the Sylvester Comprehensive Cancer Center of the University of Miami.

Leslie Crews, PhD, 2023* University of California, San Diego

Caron Jacobson, MD, 2023* Dana-Farber Cancer Institute Dr. Caron Jacobson is funded in part by a donation from the Morgan Stanley Gift Fund.

Stephen Nimer, MD, 2023* University of Miami Robert Soiffer, MD, 2023* Dana-Farber Cancer Institute David Weinstock, MD, 2022 Dana-Farber Cancer Institute Dr. David Weinstock is funded in part by Dana-Farber Cancer Institute.

Career Development Program (Scholars and Clinical Scholars) The Career Development Program provides stipends to investigators of exceptional promise in the early stages of their careers, helping them devote their careers to research in leukemia, lymphoma, or myeloma.

The Career Development Program is supported in part by a donation from Paul Leinwand.

Arash Alizadeh, MD, PhD, 2020 Stanford University Dr. Arash Alizadeh is funded in part by a donation from the Borstein Family Foundation.

Philippe Armand, MD, PhD, 2019 Dana-Farber Cancer Institute Luca Busino, PhD, 2023* Perelman School of Medicine at the University of Pennsylvania Jason Butler, PhD, 2019 Hackensack Meridian Health Grant Challen, PhD, 2019 Washington University in St. Louis

Alexey Danilov, MD, PhD, 2019 Beckman Research Institute of City of Hope Dr. Alexey Danilov is funded in part by a donation from the Margaret and Foster Madeley Family Foundation.

Matthew Davids, MD, 2019 Dana-Farber Cancer Institute Dr. Matthew Davids is jointly funded

by Dana-Farber Cancer Institute and a donation from the Oxley Household.

Courtney DiNardo, MD, 2023* The University of Texas MD Anderson Cancer Center Dr. Courtney DiNardo is funded in part by a donation from the Gordon Charter Foundation.

Lei Ding, PhD, 2020 Columbia University Irving Medical Center Areej El-Jawahri, MD, 2020 Massachusetts General Hospital Maria Figueroa, MD, 2019 University of Miami Alfred Garfall, MD, 2020 Perelman School of Medicine at the University of Pennsylvania Michael Green, PhD, 2021 The University of Texas MD Anderson Cancer Center Dr. Michael Green is jointly funded

by The University of Texas MD Anderson Cancer Center.

Daniel Herranz, PhD, 2023* Rutgers University Alex Herrera, MD, 2019 Beckman Research Institute of City of Hope Dr. Alex Herrera is fully funded by a donation from Toni and Emmet Stephenson.

Nitin Jain, MD, 2023* The University of Texas MD Anderson Cancer Center Hao Jiang, PhD, 2019 University of Virginia Alex Kentsis, MD, PhD, 2020© Memorial Sloan Kettering Cancer Center Sigurður Kristinsson, MD, PhD, 2023* University of Iceland Dan Landau, MD, PhD, 2022 Weill Cornell Medicine Andrew Lane, MD, PhD, 2023* Dana-Farber Cancer Institute Thomas LeBlanc, MD, MA, MHS, FAAHPM, 2023* Duke University Kasey Leger, MD, 2020© Seattle Children’s Hopsital Coleman Lindsley, MD, PhD, 2023* Dana-Farber Cancer Institute Frederick Locke, MD, 2022 H. Lee Moffitt Cancer Center & Research Institute Dr. Frederick Locke is jointly funded

by H. Lee Moffitt Cancer Center & Research Institute and a donation from Net Lease Capital Advisors.

Rong Lu, PhD, 2020 University of Southern California Dr. Rong Lu is jointly funded by University of Southern Califormia.

Daniel Lucas, PhD, 2023* Cincinnati Children’s Hospital Medical Center Jeffrey Magee, MD, PhD, 2022© Washington University School of Medicine in St. Louis Julia Maxson, PhD, 2023* Oregon Health & Science University Cancer Institute

©Pediatric research included in The Dare to Dream Project *Newly awarded or renewed grant in Fiscal Year 2023

The Leukemia & Lymphoma Society

2022 Acknowledgments | 1

Big Dreams, BOLD PROGRESS Shannon McKinney-Freeman, PhD, 2019 St. Jude Children’s Research Hospital Megan McNerney, MD, PhD, 2023* The University of Chicago Neha Mehta-Shah, MD, 2023* Washington University School of Medicine in St. Louis Alison Moskowitz, MD, 2020 Memorial Sloan Kettering Cancer Center Daisuke Nakada, PhD, 2020 Baylor College of Medicine Lakshmi Nayak, MD, 2019 Dana-Farber Cancer Institute Adam Olszewski, PhD, 2023* Rhode Island Hospital Dr. Adam Olszewski fully funded by a donation from the Institute for Follicular Lymphoma.

Eirini Papapetrou, MD, PhD, 2019 Icahn School of Medicine at Mount Sinai Tycel Phillips, MD, 2023* Beckman Research Institute of City of Hope Daniel Pollyea, MD, 2020 University of Colorado Anschutz Medical Campus Dr. Daniel Pollyea is funded in part by a donation from Ron and Guadalupe Cohn.

Zhijian Qian, PhD, 2019 University of Florida Christiane Querfeld, MD, PhD, 2019 Beckman Research Institute of City of Hope Dr. Christiane Querfeld is fully funded by a donation from the Schwartz Ward Family Foundation.

Kerry Rogers, MD, 2020 The Ohio State University Dr. Kerry Rogers is funded in part by a donation from the Peters Household.

Rizwan Romee, MD, 2022 Dana-Farber Cancer Institute

Nirav Shah, MD, 2023* Medical College of Wisconsin Catherine Smith, MD, 2023* University of California, San Francisco Paolo Strati, MD, 2023* The University of Texas MD Anderson Cancer Center Koichi Takahashi, MD, 2023* The University of Texas MD Anderson Cancer Center Sarah Tasian, MD, 2023*© The Children’s Hospital of Philadelphia Dr. Sarah Tasian is funded in part by a donation from Jeanne Hubbard.

Jennifer Trowbridge, PhD, 2021 The Jackson Laboratory Dr. Jennifer Trowbridge is jointly funded by The Jackson Laboratory.

G. Greg Wang, PhD, 2019 The University of North Carolina at Chapel Hill Hong Wen, PhD, 2023*© Van Andel Research Institute Jennifer Woyach, MD, 2022 The Ohio State University Dr. Jennifer Woyach is jointly funded

by The Ohio State University and donations from the Cora and John H. Davis Foundation and Schwab Charitable.

Jian Xu, PhD, 2020 Children’s Medical Center Research Institute at UT Southwestern Yibin Yang, PhD, 2023* Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center Jianhua Yu, PhD, 2019 The Ohio State University/Beckman Research Institute of City of Hope Dr. Jianhua Yu is fully funded by a donation from the Schwartz Ward Family Foundation.

Amer Zeidan, MBBS, 2019 Yale University Dr. Amer Zeidan is jointly funded by Yale University.

Michael Savona, MD, 2019 Vanderbilt University Medical Center

Career Development Program (Special Fellows and Fellows) Robert Albero Gallego, PhD, 2020© Columbia University Irving Medical Center Jeremy Baeten, PhD, 2023* Washington University in St. Louis Christopher Booth, PhD, 2023* Dana-Farber Cancer Institute Sisi Chen, PhD, 2023* Memorial Sloan Kettering Cancer Center Christina Glytsou, PhD, 2022 New York University School of Medicine Mark Hamilton, MD, PhD, 2023* Stanford University Jonas Jutzi, MD, PhD, 2023* Brigham and Women’s Hospital Thomas Koehnke, MD, 2022 Stanford University Frederike Kramer, PhD, 2023* Brigham and Women’s Hospital Rajni Kumari, PhD, 2022 Albert Einstein College of Medicine Dr. Rajni Kumari is jointly funded by Albert Einstein College of Medicine.

Qingyu Luo, PhD, 2023* Dana-Farber Cancer Institute Johanna Melo-Cardenas, PhD, 2021 St. Jude Children’s Research Hospital Dr. Johanna Melo-Cardenas is fully funded by The Mark Foundation for Cancer Research.

Sylvain Simon, PhD, 2021 Fred Hutchinson Cancer Research Center Dr. Sylvain Simon is fully funded by The Mark Foundation for Cancer Research.

Amin Sobh, PhD, 2023* University of Florida Nathan Ungerleider, PhD, 2023*© Tulane University School of Medicine Dane Vassiliadis, PhD, 2023* The University of Melbourne Therese Vu, PhD, 2021© University of Colorado Anschutz Medical Campus Dr. Therese Vu is fully funded by The Mark Foundation for Cancer Research and the Sebastian Positivity Foundation.

Elvin Wagenblast, PhD, 2022© Princess Margaret Cancer Centre, University Health Network /Icahn School of Medicine at Mount Sinai Dr. Elvin Wagenblast is funded in part by the Leukemia & Lymphoma Society of Canada.

Translational Research Program The Translational Research Program supports outstanding investigators deemed by our expert advisors most likely to translate basic biomedical discoveries into new, safe, and effective treatments, ultimately prolonging and enhancing patients’ lives.

Eugenio Morelli, MD, 2023* Dana-Farber Cancer Institute

Iannis Aifantis, PhD, 2020© New York University School of Medicine

Homa Rahnamoun, PhD, 2023* Dana-Farber Cancer Institute

Wendy Béguelin, PhD, 2023* Weill Cornell Medicine

Clara Reglero, PhD, 2023*© Columbia University Irving Medical Center Dr. Clara Reglero is funded in part by a donation from The Salah Foundation.

Matteo Bellone, MD, 2022 Fondazione Centro San Raffaele

Christopher Reilly, MD, 2023* Dana-Farber Cancer Institute Caner Saygin, MD, 2023*© The University of Chicago

Ravi Bhatia, MD, 2023* The University of Alabama at Birmingham Catherine Bollard, MD, 2023* Children’s Research Institute Grant Challen, PhD, 2023* Washington University School of Medicine in St. Louis Riccardo Dalla Favera, MD, 2023* Columbia University Irving Medical Center

©Pediatric research included in The Dare to Dream Project *Newly awarded or renewed grant in Fiscal Year 2023

The Leukemia & Lymphoma Society

2022 Acknowledgments | 2

Big Dreams, BOLD PROGRESS Brian Dalton, MD, PhD, 2023* Johns Hopkins University Randall Davis, MD, 2023* The University of Alabama at Birmingham Courtney DiNardo, MD, 2023* The University of Texas MD Anderson Cancer Center Gianpietro Dotti, MD, 2022 The University of North Carolina at Chapel Hill Ann-Kathrin Eisfeld, MD, 2023*© The Ohio State University Lucas Ferrari De Andrade, PhD, 2023* Icahn School of Medicine at Mount Sinai Terry Fry, MD, 2020 University of Colorado, Denver Dr. Terry Fry is funded in part by a donation from the Don and Lorraine Freeberg Foundation.

Alfred Garfall, MD, 2023* Perelman School of Medicine at the University of Pennsylvania Jolanta Grembecka, PhD, 2023*© University of Michigan Nitin Jain, MD, 2023* The University of Texas MD Anderson Cancer Center Ricky Johnstone, PhD, 2020 The University of Melbourne Dr. Ricky Johnstone is jointly funded

by Snowdome Foundation and Leukaemia Foundation of Australia.

Ricky Johnstone, PhD, 2023* The University of Melbourne

Jaroslaw Maciejewski, MD, PhD, 2023* Cleveland Clinic Foundation

Aileen Rowan, PhD, 2023* Imperial College, University of London

Timothy Ley, MD, 2022 Washington University School of Medicine in St. Louis

Ivan Maillard, MD, PhD, 2020 Perelman School of Medicine at the University of Pennsylvania Dr. Ivan Maillard is funded in part by a donation from Taki Donovan.

Marco Ruella, MD, 2023* Perelman School of Medicine at the University of Pennsylvania

Kathleen Sakamoto, MD, PhD, 2023*© Stanford University

Ravindra Majeti, MD, PhD, 2021 Stanford University Dr. Ravindra Majeti is jointly funded

by Snowdome Foundation and Leukaemia Foundation of Australia.

Charles Mullighan, MD, 2020 St. Jude Children’s Research Hospital Dr. Charles Mullighan is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.

Markus Muschen, MD, PhD, 2023* Yale University Nicolas Nassar, PhD, 2023*© Cincinnati Children’s Hospital Medical Center Stephen Nutt, PhD, 2020 Walter and Eliza Hall Institute of Medical Research Dr. Stephen Nutt is jointly funded

by Snowdome Foundation and Leukaemia Foundation of Australia.

Stephen Oh, MD, PhD, 2023* Washington University in St. Louis Jane Oliaro, PhD, 2023* The University of Melbourne Dr. Jane Oliaro is jointly funded

by Snowdome Foundation and Leukaemia Foundation of Australia.

Lev Kats, PhD, 2023* The University of Melbourne Dr. Lev Kats is jointly funded

by Snowdome Foundation and Leukaemia Foundation of Australia.

Bruno Paiva, PhD, 2023* Universidad de Navarra

Suzanne Lentzsch, MD, PhD, 2023* Columbia University Irving Medical Center

John Pimanda, PhD, 2021 The University of New South Wales Dr. John Pimanda is jointly funded

by Snowdome Foundation and Leukaemia Foundation of Australia.

Jonathan Licht, MD, 2023* University of Florida Richard Lock, PhD, 2023*© The University of New South Wales (UNSW) Dr. Richard Lock is jointly funded

by Snowdome Foundation and Leukaemia Foundation of Australia.

Suman Paul, MD, PhD, 2023* The Johns Hopkins University School of Medicine

Kirk Schultz, MD, 2023* University of British Columbia Dr. Kirk Schultz is jointly funded by the Leukemia & Lymphoma Society of Canada.

Mala Shanmugam, PhD, 2023* Emory University Tomasz Skorski, MD, PhD, DSc, 2022 Temple University Christian Steidl, MD, 2023* BC Cancer, part of the Provincial Health Services Authority Dr. Christian Steidl is jointly funded by the Leukemia & Lymphoma Society of Canada.

Srividya Swaminathan, PhD, 2022© Beckman Research Institute of City of Hope Dr. Srividya Swaminathan is jointly funded by Beckman Research Institute of City of Hope.

Daniel Thomas, PhD, 2023* The University of Adelaide Ashwin Unnikrishnan, PhD, 2020 The University of New South Wales Dr. Ashwin Unnikrishnan is jointly funded by Snowdome Foundation and Leukaemia Foundation of Australia.

Ryan Wilcox, MD, PhD, 2023* University of Michigan Joachim Yahalom, MD, FACR, 2023* Memorial Sloan Kettering Cancer Center Roberta Zappasodi, PhD, 2023* Weill Cornell Medicine Alex Zhang, PhD, 2022 The University of Texas Southwestern Medical Center

Christopher Porter, MD, 2023* Emory University

Translational Research Program: Renewal

Noemi Puig Moron, MD, 2023* Institute of Biomedical Research from Salamanca

Carl Allen, MD, PhD, 2023*© Baylor College of Medicine

Blood Cancer Discoveries Grant Program (in Partnership) This program is run in partnership with the Mark Foundation for Cancer Research (MFCR) and The Paul G. Allen Frontiers Group (PAFG) to support groundbreaking early-stage research aimed to advance the treatment and cure of blood cancers and potentially other cancers as well.

Robert Bradley, MD, 2021 Fred Hutchinson Cancer Research Center Dr. Robert Bradley is also funded in part by a donation from Todd Hanna.

Catriona Jamieson, MD, PhD, 2021 University of California, San Diego Ronald Levy, MD, 2021 Stanford University Ravindra Majeti, MD, PhD, 2021 Stanford University Markus Muschen, MD, PhD, 2021 Yale University Dr. Markus Muschen is also funded in part by a donation from Laurie Burns.

Susan Schwab, PhD, 2021© New York University School of Medicine Margaret Shipp, MD, 2021 Dana-Farber Cancer Institute Dr. Margaret Shipp is also funded in part by a donation from the TallenKane Foundation.

Robert Signer, PhD, 2021 University of California, San Diego Daniel Starczynowski, PhD, 2021 Cincinnati Children’s Hospital Medical Center

Alexey Danilov, MD, PhD, 2023* Beckman Research Institute of City of Hope

©Pediatric research included in The Dare to Dream Project *Newly awarded or renewed grant in Fiscal Year 2023

The Leukemia & Lymphoma Society

2022 Acknowledgments | 3

Big Dreams, BOLD PROGRESS Blood Cancer Discoveries Grant Program (LLS-funded) This program supports groundbreaking early-stage research aimed to advance the treatment and cure of blood cancers and potentially other cancers as well.

Saar Gill, PhD, MBBS, 2023* Perelman School of Medicine at the University of Pennsylvania Lucy Godley, MD, PhD, 2023* The University of Chicago Siddhartha Jaiswal, MD, PhD, 2023* Stanford University Courtney Jones, PhD, 2023* Princess Margaret Cancer Centre, University Health Network Michael Kharas, PhD, 2023* Memorial Sloan Kettering Cancer Center Peter Klein, MD, PhD, 2023* Perelman School of Medicine at the University of Pennsylvania Ari Melnick, MD, 2023* Weill Cornell Medicine Eirini Papapetrou, MD, PhD, 2023* Icahn School of Medicine at Mount Sinai Jun Qi, PhD, 2023* Dana-Farber Cancer Institute

Influential Medicine Providing Access to Clinical Trials Program The IMPACT Program intends to expand access to high-quality clinical trials to patients by bringing the trials to the patients at their local community oncology centers.

John Leonard, MD, 2022 Weill Cornell Medicine Dr. John Leonard is also jointly funded by Weill Cornell Medicine and donations from Jim Reddoch and the Wagner Household.

Gregory Nowakowski, MD, 2022 Mayo Clinic, Rochester Dr. Gregory Nowakowski is also jointly funded by Mayo Clinic, Rochester and donations from Amy and Gentry Lee, John and Louise Bryan, and Cal Turner, Jr. Michael Savona, MD, 2022 Vanderbilt University Medical Center Dr. Michael Savona is also jointly funded by Vanderbilt University Medical Center.

Tanya Siddiqi, MD, 2023* City of Hope National Medical Center Clayton Smith, MD, 2023* University of Colorado Anschutz Medical Campus.

Rising Tide Foundation for Clinical Cancer Research/LLS PatientFocused Prevention Grants for Blood Cancer This program is run in partnership to advance breakthroughs in prevention of blood cancers.

Liran Shlush, MD, PhD, 2019 Weizmann Institute of Science Dr. Liran Shlush is also funded by donations from the Wrobel Family Foundation.

George Vassiliou, MD, PhD 2019 Wellcome Trust Sanger Institute/ University of Cambridge

The IMPACT Program is funded in part by donations from Bristol Myers Squibb, Eli Lilly and Company, MorphoSys Foundation and Royalty Pharma.

Christopher Flowers, MD, 2023* The University of Texas MD Anderson Cancer Center

Hairy Cell Leukemia 2025 (HCL2025) This program is run in partnership with the Hairy Cell Leukemia Foundation to expand research in hairy cell leukemia to better characterize its biology, develop new therapies, and optimize outcomes for patients.

Omar Abdel-Wahab, MD, 2023* Memorial Sloan Kettering Cancer Center Thomas Kipps, MD, PhD, 2023* University of California, San Diego Reshmi Parameswaran, PhD, 2023* Case Western Reserve University David Ritchie, PhD, MBBS, 2023* Melbourne Health Marco Ruella, MD, 2023* Perelman School of Medicine at the University of Pennsylvania Marc Seifert, PhD, 2023* Institute of Cell Biology (Tumor Research) at the Medical School Essen Enrico Tiacci, MD, 2023* University of Perugia Thorsten Zenz, MD, 2023* Universitätsspital Zürich - Klinik für Medizinische Onkologie und Hämatologie USZ

Mantle Cell Lymphoma Research Initiative The Mantle Cell Lymphoma Research Initiative supports teams of researchers representing different disciplines and engaged in collaborative efforts to discover new approaches to treat patients with blood cancers.

The Mantle Cell Lymphoma Research Initiative is funded in part by donations from the Creel Household, the Fulenwilder Household, and the McGuire Household.

Selina Chen-Kiang, PhD, 2019 Weill Cornell Medicine Dr. Selina Chen-Kiang is also funded by a donation from Sarah Cannon Research Institute.

Larry Kwak, MD, PhD 2019 Beckman Research Institute of City of Hope Dr. Larry Kwak is funded by a donation from Sarah Cannon Research Institute.

MPN Challenge Grants This program is run in partnership with the MPN Research Foundation.

Iannis Aifantis, PhD, 2023* New York University School of Medicine Idoroenyi Amanam, MD, 2023* Beckman Research Institute of City of Hope Najla Arshad, PhD, 2023* Yale University Michal Bar-Natan, MD, 2023* Icahn School of Medicine at Mount Sinai Joan Beckman, MD, PhD, 2023* University of Minnesota John Crispino, PhD, MBA, 2023* St. Jude Children’s Research Hospital Shannon Elf, PhD, 2023* The University of Chicago Sahand Hormoz, PhD, 2023* Dana-Farber Cancer Institute Nicole Kucine, MD, MS, 2023* Weill Cornell Medicine Shinobu Matsuura, DVM, PhD, 2023* Boston University School of Medicine Joseph Michael Scandura, MD, PhD, 2023* Weill Cornell Medicine

IWMF Grants This program is run in partnership with the International Waldenström’s Macroglobulinemia Foundation (IWMF).

Gareth Morgan, MD, PhD, FRCPath, FRCP, 2023* New York University School of Medicine

©Pediatric research included in The Dare to Dream Project *Newly awarded or renewed grant in Fiscal Year 2023

The Leukemia & Lymphoma Society

2022 Acknowledgments | 4

Big Dreams, BOLD PROGRESS PedAL

Special Grants

Todd Cooper, DO, 2023*© Seattle Children’s Hospital

Maria Figueroa, MD, 2023* University of Miami

Charles Mullighan, MD, 2022© St. Jude Children’s Research Hospital

Miguel-Angel Perales, MD, 2023* Memorial Sloan Kettering Cancer Center

Kimberly Stegmaier, MD, 2021 Dana-Farber Cancer Institute Dr. Kimberly Stegmaier is funded in part by a donation from the Rally Foundation for Childhood Cancer Research.

Logan Spector, PhD, 2023*© University of Minnesota

Alexandra Stevens, MD, 2022© Baylor College of Medicine

COVID-19 Research

Equity in Access

Piers Patten, PhD, 2022 King’s College London

The Equity in Access Research Program aims to generate evidence that will guide changes in healthcare policy and practice to ensure that all blood cancer patients and survivors achieve access to the cancer care and services they need throughout their lives.

Amit Verma, MD, 2023* Albert Einstein College of Medicine

Michael Keller, MD, 2022 Children’s Research Institute

Career Development Program Achievement Awards

LLS Excellence in Scientific Service Award

The Career Development Program (CDP) supports early career scientists and physician-scientists who are pursuing a career in blood cancer research. At the end of their funding period, awardees are evaluated for their most important contributions to the field, and those with the most impactful research are given a CDP Achievement Award (CAA).

The LLS Excellence in Scientific Service award recognizes members of the scientific community who have had a profound impact on LLS by volunteering countless service hours to enhance the society’s ability to fund the best scientists and biotech companies.

Brandon Aubrey, PhD Massachusetts General Hospital Jianjun Chen, PhD Beckman Research Institute of City of Hope Noha Sharafeldin, MD, PhD The University of Alabama at Birmingham

Stephen M. Ansell, MD, PhD Dorotha W. and Grant L. Sundquist Professor in Hematologic Malignancies Research Mayo Clinic Ronald Levy, MD Robert K. and Helen K. Summy Professor in the School of Medicine and Professor of Medicine Stanford University

Saad Usmani, MD, MBA, FACP Memorial Sloan Kettering Cancer Center

The Equity in Access Research Program is funded in part by donations from Amgen, Bristol Myers Squibb, GSK, Royalty Pharma and Takeda Oncology.

Stacie Dusetzina, PhD, 2022 Vanderbilt University Medical Center Xu Ji, PhD, 2022© Emory University F. Lennie Wong, PhD, 2022 Beckman Research Institute of City of Hope

©Pediatric research included in The Dare to Dream Project *Newly awarded or renewed grant in Fiscal Year 2023

The Leukemia & Lymphoma Society

2022 Acknowledgments | 5

Big Dreams, BOLD PROGRESS Therapy Acceleration Program Partnerships Abintus Bio, Inc. San Diego, CA

Constellation Pharmaceuticals, Inc. Cambridge, MA

Immunitas Therapeutics, Inc. Waltham, MA

Sutro Biopharma, Inc. San Francisco, CA

BioTheryX, Inc. San Diego, CA

Dren Bio, Inc. Foster City, CA

Kymera Therapeutics Inc. Cambridge, MA

Travera, Inc. Medford, MA

Caribou Biosciences, Inc. Berkeley, CA

Faron Pharmaceuticals Oy Turku, Finland

NexImmune, Inc. Gaithersburg, MD

X4 Pharmaceuticals, Inc. Cambridge, MA

Carisma Therapeutics, Inc. Philadelphia, PA

ImCheck Therapeutics SAS Marseille, France

OncoPep, Inc. North Andover, MA

Immune-Onc Therapeutics, Inc. Palo Alto, CA

Ryvu Therapeutics SA Krakow, Poland

Therapy Acceleration Program Committee C. Casey Cunningham, MD Santé Ventures Chair

Francie Heller Arabesque Asset Management

James Reddoch, PhD Royalty Pharma

Robert J. Rosen, JD Greyhawke Capital Advisors

Christopher Flowers, MD The University of Texas MD Anderson Cancer Center

Ronald Levy, MD Board of Trustees of the Leland Stanford Junior University

Michael Savona, MD Vanderbilt University

Patrick J. Fortune, PhD, MBA Partners Healthcare Systems

Frederick Locke, MD H. Lee Moffitt Cancer Center & Research Institute

Therapy Acceleration Program Advisory Council Stephen Ansell, MD, PhD Mayo Clinic, Rochester Philippe Armand, MD, PhD Dana-Farber Cancer Institute Asher Chanan-Khan, MD Mayo Clinic, Jacksonville Madhav Dhodapkar, MBBS Emory University Courtney DiNardo, MD The University of Texas MD Anderson Cancer Center Giulio Draetta, MD, PhD The University of Texas MD Anderson Cancer Center Ian Flinn, MD, PhD Sarah Cannon Research Institute

Helen Heslop, MD Baylor College of Medicine Steven Horwitz, MD Memorial Sloan Kettering Cancer Center Tapan Kadia, MD The University of Texas MD Anderson Cancer Center Laura S. Kaufman, PhD, DABT Private Consultant Ross Levine, MD Memorial Sloan Kettering Cancer Center

Ruben Mesa, MD The University of Texas Health Science Center at San Antonio Vern Norviel, JD Wilson Sonsini Goodrich & Rosati Susan O’Brien, MD University of California, Irvine Daniel Pollyea, MD University of Colorado Denver, Anschutz Medical Campus

Aaron Schimmer, MD, PhD Princess Margaret Cancer Center University Health Network Robert J. Spiegel, MD Spiegel Consulting LLC Daniel Starcyznowski, PhD Cincinnati Children’s Hospital Keith Stewart, MD Princess Margaret Cancer Center, University Health Network Sarah Tasian, MD Children’s Hospital of Philadelphia Amit Verma, MD Albert Einstein College of Medicine

Steven T. Rosen, MD Beckman Research Institute of the City of Hope

Medical & Scientific Affairs Committee Advisors Janice Gabrilove, MD Icahn School of Medicine at Mount Sinai Co-Chair Jonathan D. Licht, MD University of Florida, Gainesville Co-Chair Omar Abdel-Wahab, MD Memorial Sloan Kettering Cancer Center Stephen Ansell, MD, PhD Mayo Clinic, Rochester

The Leukemia & Lymphoma Society

P. Leif Bergsagel, MD Mayo Clinic, Arizona

Renzo Canetta, MD Former Bristol-Myers Squibb

Ravi Bhatia, MD The University of Alabama at Birmingham

Giulio Draetta, MD, PhD The University of Texas MD Anderson Cancer Center

Catherine Bollard, MD, MBChB Children’s Research Institute

Christopher Flowers, MD The University of Texas MD Anderson Cancer Center

S. Lori Brown, PhD, MPH Former U.S. Food & Drug Administration, Investigations Branch

Irene Ghobrial, MD Dana-Farber Cancer Institute

Larry Kwak, MD Beckman Research Institute of the City of Hope Ruben Mesa, MD The University of Texas Health Science Center at San Antonio Susan O’Brien, MD University of California, Irvine David Weinstock, MD Dana-Farber Cancer Institute

2022 Acknowledgments | 6

Big Dreams, BOLD PROGRESS

DONORS We gratefully acknowledge the individuals, foundations and corporations that generously supported LLS’s mission during this fiscal year.

Patient Access

PP

Public Policy

R

Research

C

Campaign

Bank of America

Regeneron Pharmaceuticals

Colleen Barnhart

Rhode Island Foundation

Jazz Pharmaceuticals PA

Dr. Evelyn Bata

Robert J. Penta Foundation

BD

Mike Royal

Lang/Stiglitz Family Fund

BDO USA, LLS

SAIC

Pfizer Inc. PA

Builders FirstSource

C

Jersey Mike’s

Pharmaceutical Funding Legend PA

Institute for Follicular Lymphoma Innovation

C

Subaru of America Inc.

Century Group Inc

Salt River Pima-Maricopa Indian Community

The Lindenfelser Family Charitable Fund

Chesmar Homes Austin, LTD

Larry and Sharon Saltzman

Stephen K. Collins

Schwab Chartiable

Community Foundation

Seagen, Inc. PA

$250,000-$499,999

Consumer Portfolio Services, Inc.

Greg and Marcie Sinaiko

Amgen, Inc. PA

Daiichi Sankyo Pharmaceutical Company PA

Summit Mortgage Corporation

C

AstraZeneca Pharmaceuticals LP PA * Denotes multi-year commitment

Barclays BeiGene, Ltd. PA

$1,000,000 and Above Bristol Myers Squibb PA

R

C

C

Jeff & Mindy Binder Blue Cross & Blue Shield of Illinois

C

Ron Cohn

Gateway for Cancer Research

Elbit Systems of America

Genentech, Inc. PA PP

Summer Hall

C

Health Care Service Corporation

Gilead Sciences, Inc. PA GSK, formerly GlaxoSmithKline PA PP

C

Hairy Cell Leukemia Foundation Janssen Biotech PA Kite, A Gilead Company PA PP

C

Lisa Dean Moseley Foundation Lyon Family Foundation Norcross Foundation Pharmacyclics, an AbbVie Company & Janssen Biotech PA PP C

John Doerr

Sylvester Comprehensive Cancer Center

EKC Enterprises, Inc

TG Therapeutics PA

Enmark Stations, Inc.

The Black Family Fund

Epizyme, Inc. C

The Harold & Helen Gottlieb Charitable Foundation

F.M. Kirby Foundation

Burlington

C

The Jefferson Family C haritable Foundation

FIS Foundation Inc Barbara & Gary Freedman

The Peter DeGeorge Charitable Trust

Hearst Foundations Lara and Matthew Hjortsberg Ronald Holten

The Richard M. Schulze Family Foundation

Lisa Butler and David Holland, In memory of Maty Holland

Ibis Foundation of Arizona

The Wawa Foundation

IHOP

Larry Treen

James H. Reid, Jr. Beat AML Fund

Incyte Corporation PA

Leukaemia Foundation

J.T. Tai & Co. Foundation, Inc.

Trustar Bank

Norcross Family Foundation

Janssen Oncology & Legend Biotech PA

UCI Health Chao Family Comprehensive Cancer Center

Higgins Family Charitable Foundation

Novartis Pharmaceuticals Corporation PA C

C

Karyopharm Therapeutics PA

Truenorth Energy, LLC

C

UCLA Health / Goldman Sachs

TC Oxley

KPMG LLP

WellsFargo

Charles Schultz

James Lau

West Pharmaceutical Services Inc.

Snowdome Foundation

Amy and Gentry Lee

World Wide Technology

The Bobby Zahurak Pediatric AML Research and Patient Support Fund

Paul and Maria Leinwand

Wrobel Family Foundation

The Borstein Family Foundation

Lighthouse Investment Partners, LLC

The Frederick A. DeLuca Foundation

The Moore and Asma Families

The Marie Lamfrom Charitable Foundation

Linda Tallen & David Paul Kane Educational and Research Foundation

The Paul G. Allen Family Foundation

The Orokawa Foundation

McKesson

Amalfi Jets

Kym Rapier-Verette & Glenn Verette

The Terence J. O’Sullivan LIUNA Charitable Foundation

Morgan Stanley

Associated Bank

Nashville Wine Auction

Autolus Therapeutics PA

Anita Zucker

National Christian Foundation

BASF

Richard & Debra Oliver

Benchmark Bank & Benchmark Title

$100,000-$249,000

Opes Charitable Foundation, Inc.

Bert W. Martin Foundation

AbbVie Inc.

Clyde McGregor and Lee Ann Pederson-Pope

Blackstone Charitable Foundation

Pennsylvania Department of Health

Blue Cross & Blue Shield

PwC LLP

Blue Cross and Blue Shield of Kansas City

Royalty Pharma Takeda Oncology PA PP

C

The Don & Lorraine Freeberg Foundation The Harry T. Mangurian, Jr. Foundation The Mark Foundation for Cancer Research

Walgreens Wawa

$500,000-$999,999 Bert Ogden Auto Group Eli Lilly and Company PA PP

C

R

Horizon Therapeutics C

PA

ACE Family Foundation AMSOIL Inc.

James Liautaud

Ralph and Janice Shrader Fund

The Leukemia & Lymphoma Society

$50,000-$99,999 ADC Therapeutics America, Inc. C Alto-Shaam, Inc.

Alan and Madeline Blinder

2022 Acknowledgments | 7

Big Dreams, BOLD PROGRESS

Blueprint Medicines Corp. PA

C

Foundation

Kendra Scott, LLC

Alex & Janet Boggs

Kirkland & Ellis LLP

Sutter Health I Aetna

Allegis Group Foundation

Boise Cascade Company

KLA Laboratories Inc.

Taiho Oncology Inc. PA

Ally Financial Inc.

Brasfield & Gorrie, LLC

Cheryl Korth

Tapestry

Alston Construction Company, Inc.

Jim Broyles

Kyowa Kirin, Inc C

Ann Taylor

Margaret Anderson

Carolan Research Institute

Lehigh Valley Restaurant Group, Inc./ Red Robin

Mark Taylor

Andre Agassi Foundation

Texas Oncology

Todd Andritsch

Lenoir Charitable Trust

The Batchelor Foundation

Anrak Corporation

Christopher Lim

The Boldt Family Philanthropy Fund

Apex Imaging Services

Lowthers Family Foundation

The Hand Family

ARMKAT, LLC

Luppen Family Foundation

The Jackson Family Charitable Fund

Arnold Ventures

Williard Earl Lynn

Arrow Exterminators

Maine Cancer Foundation

The Ken and Marlene Mack Charitable Fund

Marge & Charles J. Schott Foundation

The Louis M. Plansoen Charitable Trust

Ashwood Construction

Ilana Massi

The Ping Y. Tai Foundation, Inc.

Medical Properties Trust

The Tampa Bay Lightning

Memorial Healthcare System

The Willard L. Eccles Foundation

Merck & Company PA PP

Tito’s Handmade Vodka

Audrey & Jack Harris, Megan Yowell Oglesby & Hunter Oglesby and Seth & Sara Yowell

Robert Merrick

Ken Trainer

Daren Austin

Michael Sweig Foundation

Truist

MJH Life Sciences

Upswing Foundation

Bank of America Charitable Foundation

Don Mealey Subaru Sport

Moffitt Cancer Center

Vanguard

Baptist Health South Florida

Earl D. and Marian N. Olson Fund

MSC Industrial Supply Co.

Byron & Laurie Vielehr

Joseph Baratta

El Bolillo Bakery

Net Lease

Drenda Vijuk

Fred & Jana Bartlit

Ernst & Young, LLP

Northside Hospital

VyStar Credit Union

S. Bauer

Fairway Independent Mortgage Corporation

Northwest Biotherapeutics

W.R. & Norma Ramsey Foundation

Baylor Scott & White Health

Ochsner Health System

Chip & Sarah Wagner

Bellco Capital

Fidelity Brokerage Services LLC

OU Health

Watermark Retirement Communities

Ben E. Keith Foods

Engelstad Foundation

Paul Davis Foundation

WellMed

John Bennett

GEICO

Planned Systems International, Inc

Wespac Construction

Bloomberg LP

Generac Power Systems, Inc.

Fred and Cherie Pond

Dana White

BNY Mellon

George Shields Foundation

Presidio

Wilkinson Stekloff

Jonathan Boggs

Georgia Power Company

Price Family Foundation

William R. Rich Foundation

Dan & Paula Bongino

Glen E. Tullman Fund

PSCU

Global Payments

Kyle and Erin Ragsdale

Yvette & Arthur Eder Charitable Foundation

Bonnie L. Bolding Charitable Foundation

Goldman Sachs & Co, LLC

Ray & Dagmar Dolby Fund

Michael Zemke

Dave & Kate Borowski

Gordon Charter Foundation

Rein Family Donor Advised Fund

Greater Sum Ventures

Robert E. Gallagher Foundation

$25,000-$49,999

Guardant Health

Melody & Rick Rogers

512 Main Street Inc.

Mr. and Mrs. David Hahn

Lois and Jerry Rosenblum

Aegon Transamerica Foundation

Marla Persky and Craig Heberton

Joan Rubschlager

Airtower Networks

Hibbett City Gear

Sana Biotechnology

Cantor Fitzgerald Relief Fund Administration

Akbaraly Foundation

Highmark BCBS Delaware BluePrints for the Community

Sarver Charitable Trust

Carlson Family Foundation

Ak-Chin Indian Community

Drew and Donna Schwartz

Carlton Hill Family Foundation

Hildegarde D. Becher Foundation

Bryan Schachter

Akin, Gump, Strauss, Hauer & Feld, LLP

Carol Stuhr Family Foundation

Howard Family Foundation

Brian Shanahan

ALCO LIQUIDATING TRUST

ICON, plc

Silicon Valley Bank

Alex’s Lemonade Stand Foundation

JE Dunn Construction

So Long to Leukemia

Alice Kleberg Reynolds Meyer

JLL

Erika Steiner

CDPHP Century Therapeutics

C

Chase Chemed Foundation Community First Foundation Compass Self Storage CRISPR Therapeutics

PA

Critical Start Cross Country Healthcare, Inc. CyKor Dal’s Big Hands Big Heart Foundation Dallas Promotions Data Media Associates Department of Finance Division of Treasury

The Leukemia & Lymphoma Society

Arvest Bank Astex Pharmaceuticals, Inc. C AT&T

Breakthrough Properties Bellco Buzy Family Fund California Community Foundation Shane Canestra

CaseWare International CBH Homes Centennial Bank Central California Housing

2022 Acknowledgments | 8

Big Dreams, BOLD PROGRESS

Charlotte Radiology

Patrice Fanning

John & Kristin Hyland

Marilyn Lichtman Foundation

Chelsea Morrison Foundation

Gary & Susan Farmer

Imagine A Cure for Leukemia

Material Bank

Chickasaw Nation Division of Commerce

Mike Farmer

Insight Global

Serena & Bryan Mattson

IQVIA

Greg McAfee

Chick-fil-A

Farmhouse Fraternity Association Inc.

Iron Bow Technologies

Drew McCandless

Cigna

Federal Credit Union

ISN

David & Joy McDaniel

Ciocca Dealerships

Arash Ferdowsi

J. Edgar Monroe Foundation

Mark McLaughlin

Circle City Foundation

Fidelity

James Hardie Building Products, Inc.

Mears Group Inc

Cisco Systems, Inc.

Fifth Generation, Inc./Love, Tito’s

Jennifer and Jake Skuce Foundation

Memorial Sloan Kettering

Citizens Bank

Findlay Automotive

Craig Jensen

Merchandise Pickup Service, Inc.

Citrix Systems, Inc.

First Financial Bank

Jewish Community Foundation

Kathleen Meriwether

Robert Clippard

Fletcher Jones Motorcars

Jim Turner Chevrolet

MetroStar Systems

Coca-Cola Consolidated

Florentine Camenisch Trust

Joe & Jessie Crump Foundation

Miami Cancer Institute

Richard Cole

Florida Blue

Josephine Johnson

Microsoft

Collabera Inc.

Sherry and Martin Franks

Daniel & Susan Kane

Marcia & Mark Miller

Community Health System

Steve & Phyllis Fridrich

William Miller

Complete Clothing Company

Greg Friedman

Keerat Baweja Memorial Foundation LLC

Cora and John H. Davis Foundation

Friendly Ford

Keith Zars Pools LTD

Mitek USA, Inc.

Costco Wholesale

FSI Engineering and Design, Inc.

Kenna Kunijo LLC

Moksha Aesthetics

Creative Manufacturing Properties

Furniture Fair

Richard and Gloria Kerns

Credera

Christopher Gaffney

KeyBank

Monumental Sports & Entertainment Foundation

Cronin Automotive

GalaxE.Solutions, Inc.

Zak Khan

Morgan & Morgan

Cruise Planners

Gamida Cell C

Jennifer Kipphut

Joseph Cupoli

Mary Gangelhoff

Neil and Emily Kishter

Morguard Management Company, Inc.

Thuy & Mitchell Dancik

Garber Management Group

Nicole Kline

MorphoSys US Inc. C

Darlington Shredding Company

Georgia Ports Authority

Koppers, Inc.

Morrison Foerster Foundation

Dekko Investment Services

Giant Food

Mark and Christine Kraemer

Greg and Beth Myers

Dell Technologies

Grant Thornton LLP

Kritchman Family Foundation

Nektar Therapeutics C

Minto Communities, LLC

Deloitte

Green Bay Packaging Inc

Ed and Fran Kuchar

Bryan Nelson

Delta Dental

Eric Grossman

Ed and Jennifer Kuchar

Nelson Mullins

Deltek, Inc.

Mike & Ashley Guadagnini

Lynn Kuckelman

Laura DeLuca MD

GuidePoint Security

Kumin Family Charitable Fund

Nelson Mullins Riley & Scarborough LLP

Diagnostic Centers of America

Guidewire

Laborer District Union

Dina & Andrew Wallach Foundation

Mr. and Mrs. F. Robert Hall

Carolyn Levine

Discount Drug Mart

Peter and Arlene Harman

Lion Group Inc.

DMI Personal Care

Russell Harris

Andrew & Andrea Lipman

Gabriel & Cameron Dobbs

HCA Healthcare

Vicki Logan

Dominion Energy

HCA Midwest Health & Sarah Cannon Cancer Center

Lou Fusz Automotive Network, Inc

Albon and Debbie Head

Lowenstein Sandler LLP

Martha Dudley

Helix Ventures

LPL Financial

Edith M. Schweckendieck Trust

Paul Hellman

M.G. O’Neil Foundation

Edward Jones

Heritatge Title

Michael Madoff

EFESTE

David Hitz

Robert & Emily Mahar

Elisabeth Severance Prentiss Foundation

HM Insurance Group

Malloy Toyota

Hudson Family Foundation

Craig & Susan Manske

Enterprise Holdings Foundation

Ms. Lamar Hunt

Eventbrite, Inc

Huntsman

DORFMAN AND KAISH FAMILY FOUNDATION

EY

The Leukemia & Lymphoma Society

Roberta Lowell

Anne Nelson-Debord New York Presbyterian/Weill Cornell Medical Center Niagara Cares Katrina Nietef-Wong Nolan Transportation Group North State Bank Northrop Gruman Corporation Northside Chevrolet NOVA Home Loans Nutrien NYCB Okafor Family Foundations Javier Olivan Olive Edward Oluges Optum

2022 Acknowledgments | 9

Big Dreams, BOLD PROGRESS

Orlando Health

Sehlke Consulting LLC

The James Cancer Hospital

Warmenhoven Family Foundation

Rick Ostroff

Servier Pharmaceuticals LLC C

The JEM Project Foundation

WealthOne Charitable Foundation

Ostroff Associates Inc

Sevan Charitable Foundation

David Weinstein

Tom Pang

Sewell Automotive Companies

The John and Frances Beck Family Foundation

Jeff Shaw

The John R. Oishei Foundation

Mark Weissberg

Parkview Health

Sidley Austin LLP

Wells Fargo Clearning Services, LLC

Penn Medicine Development Abramson Cancer Center of the University of Pennsylvania

Sila Realty Trust

The Lois and Richard England Family Foundation

Parexel

Performance Automotive Network Tracy and Julie Peters PhRMA Planet Fitness Plantation Ford Pledgeling Foundation PNC Art & Kathy Pope

Jim and Janet Sinegal Marietta Sirleaf Smiles of Chevy Chase Frederick Smith Iris and Michael Smith Lynda Smith & Family Tanya and Dan Snyder Solutionreach Sonecha Family Foundation

The Marcus Foundation, Inc. The McDaniel Family Charitable Fund The Parker Group, Inc. The Smith Family Charitable Foundation The Stanley and Joyce Black Family Foundation The Thomas & Agnes Carvel Foundation

Ellie Weissberg

Westcap Management LLC Whiting-Turner Contracting Company WorkForce Unlimited Bill Young Zest AI ZS Associates Irwin Zucker, In memory of Paula J. OlsonI

St. Joseph’s/Candler Health System-St. Joseph’s Hospital

The W. O’Neil Foundation, Inc

$10,000-$24,999

Verna Porter Buxton

The West Endowment

Pray Family Foundation

1889 Foundation

State of Oklahoma

Tishman Speyer

Pueblo, Inc

360MD

Steel Dynamics, Inc.

TLB Dealer Services

Quinn Emanuel Foundation

4 Wheel Parts

Rob Steigerwald

TLC Starfish Foundation

Rademacher FLP

4B Resources, LP

Don & Marilyn Steiner

Peter Tortorella

Rambus

Tour De Court

99 Ranch Market’s Tawa Charitable Foundation

Raymond James

Steve and Phyllis Fridrich Family Advised Fund

Trainer Family

A Spark of Hope

David Rendina

Stifel Nicolaus

Transamerica

A&T Subaru

Richard and Terez Abatecola Foundation

Stone Hill Winery

Trevor Loughlin Foundation

Stonelake Capital Holdings, LP

A.M. Ortega General Engineering Contractor Inc.

Richard B. Siegel Foundation

TrueNorth

Deborah Sturges/Hallmark Home Mortgage

Tucson Subaru

ABA Management, LLC

Thomas and Barbara Turriff

Matthew Abbott

Two River

Sandy Abbott

U.S. Lumber

Kashif Abdul-Rahman

UBS Financial Services, Inc.

ABFS ABM Industries Inc.

Roberta Taskar

UFC (Ultimate Fighting Championship)

Teammates For Kids Foundation

UFCW

Academy District 20

Brian and Catie Ross

Thayer Clinical Psychology Services LLC

Ultimate Kronos Group

Calstra Account

RSM US Foundation

The Beam Team

Acurx Pharmaceuticals, Inc. C

Ruoff Mortgage

UM Sylvester Comprehensive Cancer Center

The Breeden-Adams Foundation

Ryan Foundation

UNC Health

The Chaney Family Foundation

Adele S. Bernett Memorial Fund

David Ryle

United Nissan

ADP Foundation

Ryan Sabol

The Cheryl S. Barnes Revocable Trust

University of Chicago

Advent Health Orlando

Jeff & Pat Sachs

The Columbus Foundation

University of Chicago Medicine

AEP Foundation

Niki Salter

The Enrichment Foundation

Urgent Care 24/7

Aetna Inc.

Pierce and Maggie Sandwith

The Feit Family Fund

VCU Health System

AFLAC, Inc.

Sarah Tarditi Gallagher Memorial Fund

The Friese Foundation

Victoria Anne Timmis Steele Special Needs Trust

Ageless Men’s Health

The Good Works Corporation

Frank Schmidbauer

Vida Ventures, LLC.

The Handlery Foundation

Alexander Schultz

Vira Insight

The Howard Hughes Corporation

Schutte Foundation Trust E

David Wallace

The ICEE Company

John Ward

Richmond County Savings Foundation

Cheryl Sucato

Riverside Homes

Suncoast Credit Union

Robert F. Beard Charitable Foundation

Swedish Cancer Institute

Frederic Roebke Rogers Family Foundation Bob Rosen

The Leukemia & Lymphoma Society

Syndax Pharmaceuticals Inc. C

Acacia Apothecary& Wellness

Ann Adams

Agentcor Benny Agosto Jr Ron Weiss & Peggy Ahlin Raheel Ahmad Donald Aicneeley

2022 Acknowledgments | 10

Big Dreams, BOLD PROGRESS

Akel Homes

Arena Energy Foundation

Bay Electric Co., Inc.

Alair Homes

AREVO Group, Inc.

BayCare Health System

Blackwood Foundation-Taylor Blackwood

Carolyn & Andrew Albstein

Nancy Armstrong

Bayer C

BLG Trust

Alchemy Technology Group

Philip Armstrong

BCM One, Inc.

Charles Blocksidge

Alexandria Real Estate Equities, INC

Sarah Armstrong

Be Courageous

Blue Line Construction

Mr. and Mrs. Patrick Alia

Arnhold Foundation, Inc

Beam Team

Alice Ann Bien Memorial Foundation

Charles Arnold

Beam Therapeutics

Dean Allara

Art and Irma Mandell Foundation

Beaman Motor Company

BlueSky Jets

Allegheny Health Network

Arthur M Blank Family Foundation

Ethan Beard

Elizabeth Blunt

Ben Allen

Ascend Federal Credit Union

Beauchamp Maleki Group

Boatsetter

Josh Allen

Ascension Saint Thomas

Kimberly Beck

Boatyard Restaurant

Matthew Allen

Associated Credit Union

Brad and Stacey Beckworth

Bruce Bocina

Allied Associates International

Astellas Pharma Inc.

Abigail & Hampton Beebe

Kevin Boland

Allmond & Company LLC

ATAS

John Beem

Booz Allen Hamilton

Allogene Therapeutics PA

Atlantic Health System

Russell Been

BorgWarner, Inc.

Rob and Molly Allred

Atlantis Resort SPE Limited

Bell

Borrell Electric

Allstate

Atreca, Inc.

Benford Capital Partners, LLC

Boston Properties

Ally Bank

Atrium Health

Jorge Benitez

Don Bradley

altafiber

Aurora Innovations LLC Bryan Austin

Benjamin & Seema Pulier Charitable Foundation, Inc.

Yancey Bradley

Gale Altman Hortencia and Alfredo Amaya

Avalon Bay Communities, Inc.

Robert Bennett

Bradley L. Goldberg Family Foundation

Ameren Illinois

Jacee Avara

Joseph Berkes

Braman

American Endowment Foundation

Avenue Fabricating Merit Construction

Elaine Berki

Kira and Andrew Brandman

Berkshire Bank

Brandon’s Bourbon Inc.

Avera

Chris Berlow

BRANDT

American Fundraising Foundation

Michael Avidon

Charlene Berman

Lauren Brandt

American Systems

Avison Young USA Inc.

Bernard McDonough Foundation

Rosanne Brandt

Ameriprise Financial Services, Inc.

Avnet

Paula Berry

Loretta Bready

AmerisourceBergen Services Corp.

James and Laurie Axelrod

Wayne and Sandra-Lynn Berson

Lylle Breier

Ames Construction

Bach Bros Hobart

Best Egg

Roberta Brenman

Ann Amicone

Meredith Bagby

Bettina Equities Management

Sean & Cecilia Bresnan

AML Construction

Paul Baits

BGE, Inc.

Bridge Investment Group

Christopher Ammann

Kimberly Baker

Amit Bhatt

Todd Amsdell

Baker Tilly US, LLP

Martin Bicknell

Bridgestone Americas Tire Operations

Andersen Windows & Doors

Eric J. Balaguer, MD

Bicknell Family Foundation

Bill Anderson

Bilbrey Construction Co.

Anderson LLC

Balanced Environments Inc./Hard Surface Solutions

Robert Annable

Ryan Balderson

BioMed

Annette & Theodore Lerner Family Foundation

Leroy Ball

Mike and Katherine Birck

Jolee Bancroft

Birdie Box

Anser Advisory, LLC

Scott Birkhead

Anton Rx LLC

Baptist Health Louisville Cancer Care

AOW Constructions LLC

Andrew Barbieri

Birmingham Independent Insurance Agenda

Katherine Applegate

Barings

Jennifer Biry

Margaret Arakawa

Baron Family Foundation

Linda Bjelland

Dana Arcana

Tedd and Traci Barr

Bruce Bjerke

Arch Oncology

Baths of America

Black & Veatch Holding Co

American Fuels & Petrochemical Manufacturers

The Leukemia & Lymphoma Society

PA

Blue Wolf Capital Partners C

Biologics Inc.

BlueLinx Corporation

Heather Brien Briggs Equipment Brighthouse Life Insurance Company of NY Andrew & Cindy Brock Derek Brock Peter & Janice Brock Robert Brockway Jeffrey Brokish Campbell Brown Jordan Brown Ruse Brown Stephen Brown

Doug and Janet Baughman

Brown Kiely, LLP

Scott Baun

BRRH Foundation

2022 Acknowledgments | 11

Big Dreams, BOLD PROGRESS

Elyse Brubaker

Juan Carrillo

Clark Construction Group, LLC

Victor Crawford

Brutzkus Gubner Rozansky Seror Weber LLP

Carrington Charitable Foundation

Carlos Marban & Lisa Clarke

Creative Planning

Carruth Foundation

Thomas & Leigh Cleaver

Todd and Whitney Creel

Bubbakoo Burritos

Carlynn Cary

Cleveland Clinic

Crescent Lighting Solutions

Jennifer Budreau

Casey’s General Store

CM Constructors

Crest Ultrasonics Corp

Building Controls and Services, Inc.

Cassano Household

Bob Cohen

CRIF

Bullhorn, Inc

Nicholas Castellino

Cohn Reznick

Cross Country Consulting

Joseph and Mary Bundrant

Daniel & Anna Castro

Neil & Lizzy Cole

David Crow

Bungalow Scenic Studios

Graham Cathey

Cole, Scott & Kissane P.A.

Crow Holdings International

Kerry Burda

Catholic Community Foundation

Bill and Sheila Colombo

Rebecca Crowe

Burke Family Foundation

CB&I Power, LLC

Colourpop

Jonathan Crowley

Burr & Forman LLP

CBH III Investments LLC

Columbia Capital

Harold Burroughs

CBIZ

Columbia Restaurant Group

Mr. Brent Hagey & Ms. Nicollette Crowley

Tom Burt

CBRE, Inc

Abagael Combs

Crown Studios

Julie Buschman

Cedars-Sinai

Charles Combs

CSX Transportation

Amanda and George Bush

Celebrity Cruises Inc

Comerica

Cumberland Group

Andrew G. Buxton

Central Atlantic Toyota

Communities Foundation of Texas

Kelly & Blake Cunningham

BVK

Centric

Community First Credit Union

Cunningham Swaim

Dr. John & Laura Byrd

Centura Health

Brian Cuppett

Byrider

CFI Delivery

Community Hospital of the Monterey Peninsula

C. Jay Moorhead Foundation

Andy’s Challenge

Community State Bank

Roger Cusumano

C.H. Robinson

Oliver Chan

Compass

CVLUX

C3 Energy, LLC

Chao Siu Family Charitable Fund

Compass Group NA

CW Financial Services LLC

Caesars Enterprise Services LLC

Charitable Flex Fund

James Conforti

D Wilson Construction Co.

Mike Caggiano

Charles Esten

James Conley Jr

Bassil Dahiyat

Cahill Gordon & Reindel LLP

Charles McMurray Co.

Robyn & Don Conlon

Bill and Jane Dahlberg

Cambia Health Foundation

Charles Schwab

Jack and Eileen Connors

Dairy Queen Grill & Chill

Camelback Subaru

Mary Chenoweth

Conrad Shlum Charitable Trust

Dakkota Integrated Systems LLC

Cameron Memorial Community Hospital

Harry Cheung

Consonus Rehab

Dallas Stars Foundation

Chevy Chase Trust Company

ConvergeOne

Michael Daly

Chiaramonte Construction Company

Converze Media Group

Peter and Helene Dameris

Chipotle Mexican Grill

Convey Health Solutions

David Damus

Choate Construction Company

Jeffrey Cook

Randy & Deborah Daniel

Choice Hotels International

Dan and JoAnne Coolidge

Danny Addis

Sid Chowdhary

Justin & Amy Cop

Bracken Darrell

CHS AFJROTC Parents Club

Cordoba Corporation

DAT Freight & Analytics

Racheal Churchill

Berthel Corey

Sheela Dattani

CIBC

Cornerstone Building Services Inc

Ivan David

Cintas

Corporate Incentives

David S. Brown

Ciox Health

CoStar

Davis & Adams Construction Inc

Circle K

Maura & Tim Costello

Elaine Day

Citibank

Costello Inc

Dayton Children’s Hospital

Citrin Cooperman & Company, LLP

Coupa Software

Dayton Foundation

Ronald Cizzon

Courtney Knight Gaines Foundation

John Clancy

Covey Security

Deborah J Heitz and Shaw B Wagener Family Fund

Clarendon Flavors

Robert Cox

Steve DeCook

Brenda Clark

Paul Craig

Deepwatch

James Clark

Crane Composites

Matthew and Deidre Kimble

Camp Doublecreek Canaparo Family Charitable Fund Renzo Canetta David Canfield Canfor Southern Pine, Inc. Stephen Cannon Cantanzarite Family Foundation Capital Bank Capital Moving & Storage Co., Inc. Capital One Nick Capobianco Michael Capone Cardiovascular Group CardWorks Servicing, LLC Care Institute Group, Inc. Carlin and Julie Adrianopoli of The Chicago Community Foundation Carlton Fields PA

Cushman & Wakefield

Jay and Susan Clark

The Leukemia & Lymphoma Society

2022 Acknowledgments | 12

Big Dreams, BOLD PROGRESS

Del Rey Avocado

Eagle Pharmaceuticals, Inc. C

EverChain LLC

Thomas Foundanon

Delaware Orthopaedic Specialists

Earl and Brenda Shapiro Foundation

Everstream Analytics

Karl Foundation

John DeLoche

Brandon Early

Allison Ewart

Foundation Medicine, Inc. C

Deluxe

Eastdil Secured, LLC

ExactCare Pharmacy

Jonathan Fox

Dennis Nill Memorial Fund

Eastern Salt/Granite State Minerals

Fox Corporate Services

Emily Derderian

Eby-Brown

Expeditors International of Washington

Desert Institute for Spine Care

ECI/ West Coast USA Properties

Ear Eye

Frampton Construction Company

Susan DeVore

Ed Morse Automotive Group

Dan Fachner

Dianne Franco

Dezer Development

Edward Riley Bradley

Fred Fagundes

Mark Frasier

Dickinson Cameron Construction

Tony Ehinger

Lloyd Fagundes

Fred Hutchinson Cancer Center

Matt Diener

William Eisig

Robert Faktorow

Fresno Livestock Commission LLC

Dignity Health

Jesse Eisner

Farmers Empire LLC

Fresno Truck Center

Jon and Angie Dimalanta

Electric Supply

Faulkner Subaru

Friends of Katelyn

Discover

Elias, Genevieve, Georgianna Atol Charitable Trust

FedEx Ground

Lynnette Friess

Edward Fein

Traci Friess-Clark

Elizabeth McGeachin McKee Foundation

Gillian and Jesse Fein Hertzberg

Frost

Felvis Foundation

Fuel at Jewell Inc

Ella B. Cleveland Trust

Garry and Ginny Ferraris

Blake Fulenwilder

Ellen P. Kessler Foundation

Ferreira Construction Company

BARBARA FUSCHETTI

Scott and Sabrina Ellis

Ferreira Power West, LLC

Gainbridge

Scott Ellyson

Fiduciary Trust Company Int’l

Galen College of Nursing

Donald B. & Dorothy L. Stabler Foundation

Embry Health

John Fierer

Marcia Gallaher

Edward Emerson

Finaly General Contracting Corp

Eduardo Gallo

Donald Palmer Charitable Foundation

Emily Settle Fund

George Finley

Troy Gamble

Emory Winship Cancer Institute

Tracy & Kelly Finn

General Donation

Gamble & Company LLC

Empire Eye and Laser Center

Mary Clare Finney

Donegal Insurance Group

Meredith Gantcher

Enchanted Forest of Decatur

Firefighter’s First Credit Union

Donley’s Construction

Melissa Ganzi

First Media

Taki Donovan

Enerplus Resources (USA) Corporation

Victor Ganzi

First National Bank

J. Anthony Downs

Paul Engelder

Israel Garcia

First Tech Credit Union

DPR Construction

Engineer Sales Company

Hamilton Garnsey

Fiserv

Barbara Drake

Engineering Partners, Inc.

Connie and Mark Garrett

Monty Fisher

Draper Aden Associates

Ken & Linda Englebert

Kevin Garvy

Thomas Fitzpatrick

DTS Provident Design Engineering

Enterprise Holding, Inc.

Flamingo Charities Inc

Gary and Pennie Abramson Charitable Foundation

Laura du Pont

Epic

Gail & Tom Flanigan

Gary C Butler Family Foundation

Dudley Family Foundation

ePlus

Florida Cancer Specialists

Gas South

Avery Duke

Equifax

Florida Crystal Corporation

Brittney Duke

ER Bradley’s Saloon

Chase Flott

Carole Geballe Schnake and Adam Geballe

Duke Cancer Institute

Ergon Foundation

Flow Automotive, Inc.

Joe Gebbia

Duke Family Foundation

Bridget Murray and Eric Narcisco

Darren Fogel

GEHA

Thomas and Barbara Dunham

Foghorn Therapeutics

Angela Gelov

Dunham Trust Co

Eric Scherbarth Leukemia Research Foundation

George & Liz McKinnon Foundation

Troy Dunmire

Paul & Kathryn Ernst

Folsom Point Charities

Linda H. Dupree

Wilson Ervin

Forma Therapeutics, Inc.* C

George & Margaret McLane Foundation

Dutch Bros. Coffee

ESa

Rusty & Bill Duvall/Lincoln Property Company

Markus Espinoza

E. L. & Thelma Gaylord Foundation

Ethos Group Inc

H E Dishman Diversitech Corp DLA Piper LLP DLE Equipment Inc Kathleen Domm Donald & Carole Chaiken Foundation

Estate of Anneliese Kerschke

Don Forsell Fort McDowell Yavapai Nation Eric Foss

FOX Family Foundation

George and Mary Josephine Hamman Foundation John Georges

E-Trade

The Leukemia & Lymphoma Society

2022 Acknowledgments | 13

Big Dreams, BOLD PROGRESS

Gerald Jones Auto Group

Tom and Jan Hablitzel

Francie Heller

iHeart Media

John Giampoli

James Hacker

Helm Community Services CO

Imangi Studios

Craig Gibbs

Dickson Hagan

Randy Henderson

Immudyne

Jesse Giordano

Felix Hage

Henkels & McCoy, Inc.

ImmunoGen, Inc. PA

GL Marketing

Angelina Hallick

Julie Gleit

In Honor of finding cures for MN Kids

Glist Entertainment

Hallmark Housekeeping Services Inc.

Henri Landwirth and Family Donor Advised Fund Henrich Family Trust

In Memory of Iyla Shacklady

GM Advisory Group

Hampton Lumber

Wanetta Henry

Fiesta Inc

Rebecca Godchaux

Eric Handa

Ernest Herron

Waymore Inc

Godwin’s Gatorland Inc

Hands of Hope - The Foundation of Cancer & Hematology Centers of West Michigan

Christine Schumacher and Hal Hess

Independent Trust Company

Mr. David and Mrs. Judy Hicks

Infocenter.io Corporation

David Higgins

Insight Sourcing Group Institute for Cancer Research

Hannoush Jewelers, Inc

Highland Park Village Marketing Group, LLC

Allison Hanslik

Kerry Hilton

IPA Foundation

Haraden Family Foundation

Hi-Lume Corporation

Irby Construction Company

Hard Rock Hotel & Casino

Fred Hines

Isgro Pastries, Inc

Averill Harkey

Hixson Lumber Company

Harkins Builders Inc

Hobart Wealth

IU Simon Comprehensive Cancer Center

Janet Harper

Louis Hoch

J.W. Didado Electric

Shane Harpham

Greg & Stacey Hodges

Jack Buncher Foundation

Christopher & Jennifer Harris

Paul and Karen Hoelscher

Jack Henry & Associates Inc.

Harry S & Isabel C Cameron Foundation

Kevin Hofmann

Cole Jackson

Holland & Knight

Jackson Lewis P.C.

Aaron and Susan Hollander

Jackson Walker LLP

Burt Holmes

Jacksonville Florida Yard

Homrich Berg

Jacobs Engineering

Brendan Horgan

John Jakes

Hostetler Ranches, LLC

Rick James

Matthew Howard Hoxworth Blood Center

James and Gayle Halperin Foundation

HSC Aquisition, LLC

Janitronics

Jeff Huber

Brian Jaramillo

Huber Engineered Woods

Jeannette and H. Peter Kriendler Charitable Trust

Jane Goei Goldberg Weprin Finkel Goldstein LLP Golden Wings Donald Goodman James Goodwin Gordon Industrial Supply Co. Cory Gourley GovSmart Laura and Mike Grace David and JoAnne Graham Graton Resort Virgina Graves Rick Gray Greater Kansas City Community Foundation Greenberg Traurig Greene County 4-H Livestock Clubs Greenhill & Co., LLC Greenstein Delorme & Luchs, P.C. David Gregory Mark Gregory Gregory Greenberg Children’s Foundation

Todd HANNA

Denise Hartmann Harvard Maintenance, Inc. Harvey Builders Richard Haskins Hatton Foundation Raymond Haupt Haymakers for Hope Cornell Nelly Haynes Jr. HB Wealth Management, LLC HCL Technologies

Greystar Development, LLC

Health Carousel

Louise & Guy Griffeth

Health Foundation for Western & Central New York

Lindsay Grimes Anne Groh Grossmont Healthcare District David Grunenwald GTCR LLC Guggenheim Life and Annuity Co. Gunster Mik & Heidi Gusenius Gustaf W. McIlhenny Foundation Roger Guthrie Guthrie Inc. H3 Biomedicine H8 Cancer Foundation

The Leukemia & Lymphoma Society

HealthONE James Healy Hearst Media James Heavener HEB McAllen #590 Linda Hedderman Jim Hedrick Holly Heer Sheila Heinze Heisley Family Foundation Helena and Tom Stokes Family Foundation

Nancy Hughes Hughes Management Group Hulk LLC Humana Hunt Family Foundation Hunt Ventures

C

Investors Bank

Jefferson Bank Tom & Virginia Jennaro John Jennings Jennings Air & Mechanical Erik Jensen

Huntsman Cancer Institute

Jerry Parins Cruise for Cancer Fund, a fund of the Greater Green Bay Community Foundation

Niles and Ginger Hushka

Jim Ellis Family

Hyperion Partners

Michael Jingoli

Hy-Vee

Jingoli Power

IBC Bank

JLB General Agency LLC

IBERIABANK/First Horizon

JOGUE INCORPORATED

IDI Consulting

Jonathan John

Roberta and Luis Huntington

IEI Technology USA Corporation

2022 Acknowledgments | 14

Big Dreams, BOLD PROGRESS

John Newell Wade Foundation

Sarah Keymer

Eraldo LaPietra

Lawrence Lum

Amy Johnson

Christopher & Lindsay Keyser

Andrew Larew

Lument

Daniel & Cynthia Johnson

Akbar Khan

Lauren Lash

Yongbin Luo

Diana and Murray Johnson

Kichler Lighting

Latham & Watkins LLP

David Luski

Kaelan Johnson

Kimray Inc.

Laughlin-Beers Foundation

LYNDSI & MATT

Stacey Johnson

Kindred Healthcare

Lauren Lash Designs

M Fried

Johnson Controls

Jim King

Robert Lavina

M&T Bank

Jon & Mindy Gray Family Foundation

Wanda King

Lawrence and Carleton Mowell Fund

M&T Bank Charitable Foundation

Billy Jones

King & Spaulding LLP

Lazar Industries

Mabel Foundation

John Jones

Kinsley Ray 5K

James and Mary Lazzari

Madera Real Estate Group

Joseph & Catherine Johnson Family Foundation

Laura Kipphut

Amy Lee

Mallinckrodt Pharmaceuticals C

Rick and Michelle Kirby

Jerry Lee

Ellen Mamn

Joseph and Mary Fleischacker Family Foundation

Steven Kirz

Robert Len

Beverly Mancebo

Kathryn And Luke Kissam

Lenkersdorfer Inc.

Kivort Steel, Inc.

LEO Construction Company

Margaret and Foster Madeley Family Foundation

Klapach & Klapach, P.C.

Leon S. Peters Foundation

Marilyn & Larry Margolis

Don Klein

Ellen Leritz

Mark T. Sheehan High School

Jonathan & Robin Klein

Ronald Levit

MarketOne Builders, Inc.

Margaret Klenzing

Levitsky-Zuckerman Family Fund

Anthony Marnell IV

Rochelle Klutch

Lewis Giving Fund

Marquee Homes, Inc.

Denise Knierim

William Lia

Marsh & McLennan Ageny

Koch Companies Community Fund

Lia Auto Group

Marsh Insurance

Kolache Factory Inc.

Liberty Mutual Group Inc.

Lori Martin

Kirk Konet

Life Vac LLC

Lucy Martin

Koons Tysons Toyota

Lift a Life Novak Family Foundation

Mary Lou’s Coffee

Koppers Railroad Structures

Liljenquist & Beckstead of VA

Marya Stansky Charitable Gift Fund

Kornegay Company LLC

Troy Link

Masco Corporation

Michael Kouyoumdjian

Lion & Blue Bear Foundation

George Stephen Mason, Jr.

Charles Kriser

Lisa Bilotti Foundation

Masonite

Krista & Bryce Horton

LAWRENCE LITWACK

Massey Services, Inc.

Lois Kroll

Kevin and Tracey Litwin

David Massimilla

Frank J. and Mary E. Kruse

Anna Liu

MasTec

Anoop Kumar

LJA Engineering

Masters Capital Management, LLC

Three Llc

Matson Navigation Company, Inc. & Subsidiaries

Josephine Charitable Foundation JPMorgan Chase JSR Micro Jural Couey Carter Trust Justin Chueh and Pauline Shuen K & D Management, LLC K Machine Industrial Services Matthew Kabaker Kadilhen Foundation Rita Cavanagh and Gerald Kafka Kairos Government Affairs Kirk Kaminsky David Kamo Jordan Kaplan Lawrence Kaplan Fares Kargar Peter Karmanos, Jr Jonathan and Tammy Karnes Donald Karpinski Kearney & Co Keck USC Keeler Motor Car Company Dave and Annie Keffer Shaun Kelleher Kellwood Foundation Ken Anderson & Associates Craig Kennedy Linda & Greg Kennedy Douglas Kenny Patrick Kenny Carol Kerins Ryan and Jessica Kerrigan Toner Kersting Kettering Cancer Care

Kura Oncology

C

Kymera Therapeutics

C

Kim Llewelyn

L & J Vanderham Dairy

Amanda Lloyd

Labor Works LLC

Mike & Wanda Lloyd

Roger LaBoube

Locke Lord LLP

Darryl & Ellen Laddin

Lockton Companies LLC

Lahood Properties

Lon V Smith Foundation

Lainie’s Angels

Lorenzen Candle Co.

LAND DESIGN CONSULTANTS, INC.

Mathew Lori

Landaas and Co LLC

Lee & Trey Loughran

Landsouth Design Studio

Larry and Janice Lowder

Tracy & Ben Lange

LP Building Solutions

Langley Federal Credit Union

Luca’s Ride For AML

Trish Lanoha

Ludeman Insulation & Supply

Maurice & Judi Falk Foundation Sara Mayer Mayer Brown LLP Mayo Clinic Mays Family Foundation Shelley Mayse David Mazzotta Courtney Mccarthy Michael McCarthy Thomas McCarthy MICHAEL MCCORKEL Tammy McFarlan

Dick & Connie Luebke

Kevin and Robyn McCarty Charitable Fund

The Leukemia & Lymphoma Society

2022 Acknowledgments | 15

Big Dreams, BOLD PROGRESS

Bailey Mcguire

Miller Pipeline Coporation

Joseph Netherland

Brian ONeill

Glenn McKenzie

Brian Millham

Neuberger Berman

Open Lending

McKinsey & Company

Karen Millner

Nevada Community Foundation Inc.

Optim Orthopedics

Edward & Stephanie McLaughlin

David Millsaps

New York Oncology Hematology

Optimize Rx

Allyson McMahon

Milo’s Tea Company, Inc.

Charles Newman

Oracle America, Inc.

McManamy Jackson Hollis LLC

Laurie and Nate Minc

Matt & Martha Newsom

Orca Biosystems Inc. C

Jennifer McNeil

Christina Minnis

Walter Newsom

Orthodynamics Company, Inc

William McNitt

NFI Industries

Maura O’Sullivan

Shari McNulty

Mintz, Levin, Cohn, Ferris, Glovsky and Popeo

Nicholas A Caspero & Tomiko Va

Linda Outlaw

Daniel and Debbie McQuary

MJC & Associates

Bradley Nicklin

Outlyr

MDC Richmond American Homes

MM Finance, LLC

Stephen Nimer, MD

John Owen

MDC/Richmond American Homes Foundation

Modern Yachts LLC

Nix Patterson, LLP

P&A Group

Mohawk Insurance Services

Pacific Service Credit Union

MDU Resources Foundation

Momma Has Goals LLC

Norris and Debra Bishton Foundation

Robert Mead

North Park Subaru

Cari Palmer

MEDHOST

Montefiore Medical Center--Oncology

Northern Regional Hospital

Chris Panczner

Media Information Services, Inc.

Monterey Private Capital Inc.

Northern Trust

Papa Johns

MediRevv

Moody Family Foundation

MedPace

Charlie and Wendy Moore

Northrop Grumman Charity Custodial Account

Parallon Revenue Cycle Point Solutions Division

Medstar Shah MSO LLC

Thomas Moore

Northshore Community Fdn

Alan Parham

Lucas Meeker-Harry

Elizabeth Moran

Norton Healthcare

Max Parker

MEI Pharma, Inc. C

Brett Morris

Novant Health

Parker Hannifin Corporation

April Meier

Thomas Morrison

Parkview Ortho Hospital

Joseph Meisner

Robert Morse

Novartis Institutes for BioMedical Research C

Meltzer Group

Teddy Morse

Nurix Therapeutics C

Memorial Sloan Kettering Cancer Center

Moss Construction

Nutrient

George Moss Jr

NV5

Mercedes Benz of The Woodlands

Mother Murphy’s Labs, Inc.

NVG Corporation

Mercedes-Benz of Coral Gables

MRM Foundation

Oakwood Bank

Mercedes-Benz of Cutler Bay

Jenn Mueller

Josh Obannon

Mercury Financial

Patrick Mullaney

Lynne & Greg O’Brien

Bronson Meredith

Frank Mungo, Jr.

Lynne O’Brien

Jon Merksamer

Gail and Timothy Munzing

Dolores O’Connell

Phillip and Caren Merrick

Murphey Candler Baseball Inc.

John & Rhonda O’Donnell

Merritt Companies

Bill Murski

Randy Oehrlein

Methodist Healthcare Ministries

David Mutnick

Josh & Tina Oertli

Metrie Inc.

Mutual Group

OG&E

Jennifer Metro

National Financial Services LLC

Ohio’s Electric Cooperatives

Jim Meyer

National Grid

O’Keefe Lyons & Hynes, LLC

Lenore and Dale Meyer

National Philanthropic Trust

Shelby & Jeff Oksman

Meyer Klein Group - Thrivent

Nationwide Legal, LLC

Jim O’Leary

MHC Kenworth

Natural Designs Landscaping

MI Windows and Doors LLC

Swati Navani

Olive I & Eunice J Toussaint Family Foundation

Bob and Brenda Michaels

Navarro Family Foundation

Michigan Insurance Company

Marjie and Tom Nealon

Midstream Energy Partners

NearShore Technology

Mary Milbert

Nebraska Medicine

Charles and Tammy Miller

Brian Nelsen

David and Alejandra Miller

The Leukemia & Lymphoma Society

Amanda Olson Leslie Olson Omaha Community Foundation

Paley Rothman

Parnassus Investments Mary Parsons Alissa & Justin Partee Pascua Yaqui Tribal Passion Growers Milan Patel Payal Patel Patheon Pharmaceuticals Inc. C PathGroup, Inc. PatientPoint Patriot General Engineering Inc. Paul & Beryl Greetin Foundation Paul Hastings LLP Express Pay Payden & Rygel Amber Pearce frank pechacek Chris Pedersen Marguerite Pelissier Penn Medicine Center for Cellular Immunotherapies Arnold Penner

Omeros Corporation

Pennsylvania Wireless Association Inc.

Onco360

Robert J. Penta

One Workplace

Pentair Foundation

2022 Acknowledgments | 16

Big Dreams, BOLD PROGRESS

Pentwater Capital Management LP

Qlik

Jay Rittberg

Barbara Sass

Pershing LLC

Quality King

RLB Squared

Saunders Construction Inc

Ronnie Pertnoy

Dustin Qualls

RNC Industries LLC

Savannah Vascular Institute

Petillo Inc

Dan & Marilyn Quayle

Mike Roark

Alexandre Saverin

Petros Homes

R.G. Miller Engineers, Inc.

Roberts Oxygen Company, Inc.

Savvy Enterprises

Josh Petry

Rabbitt Whalen Family Foundation

Johnathan & Shannon Robertson

ScanSource

Phase 2

Michael Raber

Ruth Robinson

James and Sally Scapa

Philadelphia Performing Arts Charter School

Ralph C. Wilson, JR. Foundation

Scott Robnett

Arlene Schafer

Ralph Lauren Corporate Foundation

Rock the Campus

Mark Scharfman

Pi Kappa Alpha Fraternity

Rene Ram

Rockefeller Group

Steve Schaub

Martha Picciao-Mazor

Rockford Construction

Nate Schermerhorn

Pier 92 Restaurant Inc

Ramón Worthington Nicolas & Cantu, P.L.L.C.

Bonnie and Sam Roditti

Elizabeth Schlesinger

William Pierce

rand* construction

Rodrock Homes, LLC

Liz Schlesinger

Pike

Karen Rankin

Scott Roeder

William and Nathalie Schmicker

Pinecrest Endowment Fund

Barbara Rapaport

Jesse Rogers

Charyl Schroeder

Mandy Pinion

Dr. Ben Mibab & Mr. David Ray

Vicki Rollins

Richard Schultze

Pinkerton Foundation

RBC Wealth Management

ROMA Charitable Foundation

Gerald Schultzmicrometl

Pinnacle Financial Partners

RBW Logistics

Nancy Romankiewicz

Schusterman Foundation

Craig Pisani

RE/MAX

Patrick Ronan

Schutte Foundation 1959

Robert Pisani

Tim and Luanne Reagan

Rosa Madera- Team Just Love

Marvin & Donna Schwartz

Michael Pitcher

Rose Paving

Kevin Scott

Michael Pittman

Real Estate One Charitable Foundation

Alexander Roth

Stacy Scott

Pittsburgh Financial Consultants

Susan Reale

Jennifer Roth

Tim Scott

Pivot International, Inc.

Red Robin

Mary Roth

Samuel Scott, III

Playa Bowls Princeton LLC

Red Rocks Church

Mary L. Rowan

SCP Health

Plexus Capital

Donna Reed

Christina Rowland

Scripps

James Plutt

Reed Family Foundation

RPM XConstruction LLC

Chris Scruggs

Pomeranz Household

Refuel, Inc

RSM

Kenny Braverman & Liz Sczudlo

Allison Pon

Mark Regante

RT Specialy

Sea Salt & Sugar

Pond Roofing Company Inc

Andrea Reid

Rubenstein Charitable Fdn

Sears Contract, Inc.

David Porter

Reid Family Charitable Fund

Seth Rubin

Sebastian Positivity Foundation

Talmage Porter

Reily Foods Company

Rubius Therapeutics C

Glen See

Erik Powell

Relentless 5k

Alex Ruiz

Loutishia Powell

Reliant Energy Systems, Inc.

Randy Rushing

Doug and Ruthann Seely (in honor of Anna)

Powers Aquatics

Renaissance Charitable Foundation

Russell Family Charitable Fund

SEFCU

Powerserve Int’l

Marjorie Rendina

Russell Reynolds Associates Inc.

Selective Insurance

PPD Inc

Rendina Healthcare Real Estate

William Paul Rutledge

Sensiba San Fillippo

PRA Group, Inc.

Republic Bank

Patrick Ryan

Peggy & Carl Sewell

Precision Biosciences, Inc. C

James Resnick

Michael J. Ryan, Jr.

Seyfarth Shaw LLP

John Preston

Restoration Management Company

Barbara & Robert Sablowsky

Sgt Mark Antonowitsch Fdn

Timothy Presutti

Reynolds & Reynolds Associate Foundation

Sagis, PLLC

Faisal Shaikh

SailPoint Technologies

James Shanahan

Salinas Valley Memorial Hospital

Eddie Shea

Salmo Investments LLC

Tom & Kathy Shea

Sam & Peg Johnson Family Charitable Fund

Shell Oil Company

Sam Swope Family Foundation Inc.

Harold Sheroff

San Antonio Spirit

Sam & Becky Sherstad

Sahil & Mana Sanghvi

Sam Sherstad

Priority Physicians PC Professional Emergency Physicians Progressive Design, Inc. Prone Family Foundation Prosperity Bank PSIOG Digital Private Limited Ron Pusey

Reynolds & Reynolds Co Meredith Rice Rich Dalessandro Memorial 5K Richard Squier Pallet, Inc. Richard W. Stayner & Ronda D. Stayner, a donor Advised Fund of Renaissance Charitable Foundation

PVH Corp.

Jamie & Jennifer Riesterer

Pye Barker

Cody Ritchie

The Leukemia & Lymphoma Society

Wade Sherman

David Shevsky

2022 Acknowledgments | 17

Big Dreams, BOLD PROGRESS

Shannon Shipley

Spaulding Medical LLC

Syros Pharmaceuticals, Inc. C

The Hawthorn Group, LC

Matthew Shirah

Spectrum Health

Taneja Family Foundation, Inc.

The Hight Family

Margo Shoup

Amy Spencer

Tarlton & Sons, Inc.

The Hirsch Family Foundation

John Shumate

Carol and Mark Spisak

Taylor Farms

The James Broyhill Foundation

Bart Sichel

SPM Foundation

TCWGlobal

The Journeys Group

Sidney, Milton & Leoma Simon Foundation

Mark & Christy Sponseller

Team Just Love

The Kaplan Family Fund

SquadLocker, Inc.

TECO Energy, Inc.

The Kay Family Foundation

Michael Siegel

Square 22

Katherine Tedrick

The Keene Family

Susan Siekierski

St. John’s United Church of Christ

Tee Off Against Corp.

The Kirby Smart Family Foundation

Sierra Pacific Mortgage

Kriss Stackhouse

Guido Teichner

The Laverna Hahn Charitable Trust

Signature Bank

Diane Stamatelatos

Tekton Research, Inc

The Luminescence Foundation, Inc

Jerome Silber

Danuel Stanger

Tennessee Oncology

The Marsal Family Foundation

Al Silva

Sean and Jen Stanton

The Meridian Group

Alan Silver

Star One

Lee (Tepper) and Dorine (Real) Tepper & Real

Silver Lining Wealth Advisors

Terakeet

The Nelson Company

Kyle & Stacia Simmerman

Steel Dynamics, Inc./Structural Rail Division

Terumo Blood and Cell Technologies

The New England Patriots Foundation

Lauren & Robert Simmons

Steele Foundation

Texas Health

The Oliver Family Foundation

linda simmoons

SteelFab, Inc.

Texas Instruments

The Ordan Family

Mike & Reid Simons

Darren Steenhoek

TGIG, LLC dba The Grove

The Papadopoulos Family Foundation

Stacy and Jason Simpson

Jennifer and John Stelly

Simpson Thacher & Bartlett LLP

Sterling

Thalia and George Liberatos Foundation

The Phyllis M. Coors Foundation in Memory of Maxine Hurt

Patricia & Richard Sinaiko

Peter and Sandy Stern Chasity Stewart

the A Little Good, a fund of The Indianapolis Foundation

The Pomponi Family

Joe Sinclair Jasvinder Singh

STG Partners Merrill Lynch

The RAST Foundation

Singleton Family Foundation

Stock Yards Bank and Trust

The Adam Puritz and Robin Neiterman Fund

Dr. Brett T Brinker and Dr. Heather A. Slay

Mona Carlton Stogner and Grey Stogner

The Alaska Community Foundation

Dona Smith

John and Jane Stoneman

The Antibody Society Inc.

Douglas and Phyllis Smith

Stonies Taphouse & Bistro

The Barry S. Sternlicht Foundation

Iris Smith

Strat Hotel Casino & Skypad

The Bhojwani Family Charitable Fund

Jenifer Smith

Stacey Stratton

The Bill Bass Foundation

Jill Smith

Stream Realty Partners

The Blackstone Group

Kathy Smith

Studios at Fischer

The Blue Lagoon Foundation Inc.

Kiernan Smith

Riley & Sarah Stuebe

MC Smith

Kathy Stypula

The Brad Blumenfeld Family Foundation

Nicole Smith

Robert “Sully” Sullivan

The Chotin Foundation

Richard and Novelle Smith

William Sullivan

The Correll Family Foundation

Smith & Associates

Sullivan & Cromwell LLP

The Cutinho Family

Peter Sniderman

Sumitomo Pharma Oncology

The Darla Moore Foundation

Josh Snow

Summerwood Partners, LLC

Snowflake

Sunbelt Rentals

The David Spence Cancer Foundation

Sofinnova

Daniel Sunderland

The Dorsey & Whitney Foundation

Albert Sohn

Super Herber Bros Foundation

James Solomon

Surack Family Foundation

The Edward G. & Kathryn E. Mader Foundaton

South Denver Windustrial

Frank Surface

The Eli and Edythe Broad Foundation

Southern Rivers EMC

Susan Bogin

The Elpis Foundation

Spangler Subaru

Gene Sykes

Spartanburg County Foundation

Synchrony

The Ethel and Harry Reckson Foundation

Synovus

The Leukemia & Lymphoma Society

The Almond Company

The Fishel Company

The Natori Company

The Rachel Ray Foundation The Rhoda and David Chase Foundation The Robert and Nancy Reiner Family Foundation The Robert R Sprague Foundation The Roderick Seward, Flossie Radcliffe and Helen M. Galloway Foundation Inc. The Salah Foundation The Sam J. Frankino Foundation The Sandy Hill Foundation The Seth and Stacey Blackman Charitable Fund The Shack Sackler Foundation The Shaw and Betty Walker Foundation The Signorelli Company The Spencer Company The Stanley M. Marks Blood Cancer Research Fund The Stephen M Sander Fdn Inc The Szabo Family The Thomas Spiegel Family Foundation The UHV Fund The University of Kansas Cancer Center The Vinik Family Foundation

The Garcia Companies

2022 Acknowledgments | 18

Big Dreams, BOLD PROGRESS

The Whicker Family Foundation

U.S. Bank

Brad & Tiffany Vick

Joel Wiegert

The William, Jeff, and Jennifer Gross Family Foundation

U.S. Charitable Gift Trust

Lois Vick

Willco Construction Company Inc.

U.S. Electrical Services Inc.

Katy Vickery

Willdan Group Inc.

The Woodall Family Charitable Fund

UAB Medicine

Vinson & Elkins L.L.P.

Beth Willett

Theda Care

UAMS

Ann Vivell

William A. Hagan, Jr. Foundation

Theodore R. Meyer Charitable Gift Account

UBS

Vivian Health, Inc.

William H Kopke Jr., Inc.

UCHealth

Vivian L Smith Foundation

William J. Shaw Family Foundation

UFP Inc.

Vizient

Greg Williams

Mindy Uhrlaub

Vogel Family Foundation INC

John Williford

UHS of Delaware, Inc.

Landria Voigt

Willoughby Construction

Ullico Inc.

Vor Biopharma C

Willowbrook LLC

Unanet

W. MI Biggby Advertising Group

Wilson Sonsini Goodrich & Rosati

Susan & Williiam Wagner

Windsor Fine Jewelers

Thrivent Financial

UNC Lineberger Comprehensive Cancer Center

Michael Wahlstrom

Sam Winegrad

TIAA

Uniform Firefighters Associati

Walentas Foundation Ltd

Tigerfight Foundation

Union Bank of California

Iris Walker

Wings Over Leukemia and Lymphoma Inc.

David, Jennifer Chris and Diana Tilton

United Health Care

Walker & Dunlop, LLC

Joseph Wire

Kim Tindall

University of Iowa Healthcare

Stephen Wall

Wisenbaker Builder Services

Tinker Street

University of Kentucky Markey Cancer Center

Walmart

Wolcott Rivers Gates

Freda Wang

Jerome Wood

University of Michigan Rogel Cancer Center

Warburg Pincus

Woods Foundation Dave Wooster

University of Texas - Rio Grande Valley

Greg Ward Karen Warner

Workscapes

UPMC Pinnacle

Washington Gas

Worldnet Inc.

UPS GENERAL SERVICE

Watson Wise Foundation

Mason Wright

Wade Upton

Michael Waxman

Jacky Wu

Michelle Urban

WBM Heritage Roofing Inc

X4 Pharmaceuticals, Inc. C

URL insurance group

Stephen Weber

X-Caliber Capital

V Fine Homes

Linda Webster

Xencor, Inc

Jeff Vacirca

Jacqui Weigman

Keith Yandell

James Valentic

Dana Weinstein

Daniel Yevcak

Valero

Weiss Household

Chong Yi

Valley Children’s Hospital

Shari & Marc Weissbach

David Young

Vanda Pharmaceuticals Inc. C

Irving & Ann Weissman

Zalik Foundation Fund

Vault Bill Pay

Richard Wells Pratt

Zangmeister Center

Trust Company of the South

Vecellio Family Foundation, Inc.

Charles Wert

Shad Zapalac

Tullett Prebon Americas Holding

Shannon Venable

Wesco Distribution, Inc.

Zapalac/Reed Construction

Suzan Tunder

Venable LLP

Robert West

Andrew Zetterman

Lori & Richard Turbe

Venture First

Westchester Prosthodontics

Zurich American Insurance Company

Chad Turner

Philip Verwey

Westin Homes

Joseph Zvesper

Turner Construction

Therigy, LLC Therma-Tru Corp Thermo Fisher Scientific Bruce and Lyndell Thiessen Thomas Jefferson University Liam and Felicia Thornton

Titan Advisors LLC TJS CONSTRUCTION Tony Cook and DCPG Memorial Fund Michael Tooley Tooley Oil Company Towbin Motorcars Tower Hill Insurance Towne Properties Asset Mgmt Co Tractor Supply Company Beth Trammell Trammell Crow Company TransUnion, LLC Gregory and Tamika Tremaglio Tri Counties Bank Troutman Pepper Hamilton Sanders LLP

Thomas Turriff Erik Tutor

The Leukemia & Lymphoma Society

Weyerhaeuser Joe Wickman

2022 Acknowledgments | 19

Big Dreams, BOLD PROGRESS

TOP FUNDRAISING SUPPORTERS #hELLAtough

Audrey Batcheller

Ann Cameron

Ronda Conger

#LetUsTellerAboutTheCure

Bauer Power

Cancel Cancer

Megan Costa

Abby, Arabella, and Emma’s Team

Gurshaman Baweja

CANCER CRUSADERS

Cousins For A Cure

ABC: Abolish Blood Cancer

BC We Care

Cancer Destroying Crew (the CDC)

EJ Cox

Nancy Adair

Katie Beckworth

Cancer Eradicators

Henry Coy-Burt

Emily Ahmed

BeePositive

Cancer Kickin’ Crew

Tanner Crane

Ainsley, Joelle, and Piper’s Team

John Bennett

Cancer Killers

Creel Family Philanthropies

Alexander Akel

Daniela Berlinski

Capital Bank

Cross Country Healthcare

Evelyn Akers

Aleshia Berthel

Charles Cariello

Tracy Croxen

Tom Alban

Caroline’s Cure Team

Cruisitude for a Cure

Nicole Albstein

Beta Chapter of Sigma Alpha Epsilon

Juan Carrillo

Jennifer Culhane

Sergio Alejo

Randy Bilger

Carter’s

Kelly Cunningham

All in for a Cure

Kevin Bjerke

Carver Porter’s Team

Cureone

ALL In The Family

John Scott Black

Lori Cavallo

Allegro 2021

Blackstone AMBBR 2022

CCF Cleveland Clinic

Curing Cancer Never Goes Out of Style

Allen Wasinger Fundraising Team

Marcie Blanco

Matthew Chan

Tanya Curry

Allie’s Team

Blessed to Fight

Sandra Chancey

Carly Daigle

Ally

Blood Bound

Mark Chao

Daiichi Sankyo

Chris & Jill Ammann

Bloomberg Fall

Charity Price’s Campaign Team

Thuy Dancik

Amy Johnson’s Campaign Team

Christopher Bolio

Charles Esten’s Team Addie

Dave Wooster’s Campaign Team

Sunil Ancha

Bonnie Dickey’s Team

Charlie’s Angels

Deborah Sturges’ Team

Bill Anderson

David Borowski

Chasing Cures 2.0

Decade of Magic

Karla Anderson

Borzou Azabdaftari’s Campaign Team

Chris Bolio’s Campaign Team

Natasha del Barrio

Chris Pero’s Fundraising Team

Linda Delaney

Christine Mills’ Campaign Team

Meghan Delaney

Justin Chueh

Delta Difference

Circle of Hope

Emily Derderian

Lehigh Valley Circle of Hope

Capri Dessecker

Cisco Systems RTP

Maryanne Diaz

Corina Clark

Bonnie Dickey

Marty Clark

Courtney Dickey

Coast to Coast Cures

Martin Dietrich

Margaret Coats

Dominion Energy

Ilyse Cody

Julie Donaldson

Zach Coggins, CRPC

Murry Donaldson

Cole Williams’ Team

Double A Saves the Day

Colin Burda’s Team

Driving Forward for a Cure

Colin Fitzgibbons’ Team

Halleigh Duff

Collabera

Matthew Duffy

Robyn Collums

Chrissy Dunlap

Columbia Kicks Cancer

Eagle Mission...Soaring Above Cancer

Andrei The Brave Andrew Wallace LLS Team Annali Leach’s Team Anne’s Warriors Michael Annessa Answer 4 Cancer Answer for Cancer Holly Ashbrook Logan Ashton Casey Atwater Sherrie Austin Avery Knox and Marcus Miller’s Team

Maggie Boucher Taylor Bousfield Carrie Bradley Melvin Bradley Brady’s Battle Mike Brannock Brave for Brase Brian Kozera’s Team Bridge Investment Group Bristol Myers Squibb Bronwyn Vance Brooklyn Blood Battlers

Justin Ayd

Connor Brown

Borzou Azabdaftari

Secelia Brown

Cindy Bachicha

Builders FirstSource

Shelby Badillo

Building Hope

Lauren Bailey

Bullpups Beat Cancer

Madeline Baltz

Steve Burnett

Deirdre Bambrick

Elaine Burrell

BAN Blood Cancer

Katie Burris

Alicia Barahona

Tom Burt CALLING TO CURE from the 804

The Leukemia & Lymphoma Society

Combat Cancer Coming for Cancer Compass Self Storage ConCUREing Cancer

Eagles for the Cure Eagles Soar For a Cure Edith Brockway Kenna Ehman

2022 Acknowledgments | 20

Big Dreams, BOLD PROGRESS

Eric Eissenstat

Casey Gocel

Matt Hohorst

Kickapoo

Elbit Systems of America

Madison Godinho

Carlito Holt

KickinCancer

Elections Systems & Software

Jeremy Goldstein

Horizon Therapeutics

KIEp FEITing

Ellie Payne’s Team

Got CUREage!

Tracy Howard

Eric King

Ely Mendieta

Leslie Gottfried

Xixi Hu

Jim King

EntrepreCURE’S

Gracelynn Hyman’s Team

Nancy Hughes

King Cares

Joe Erwin

Grant Schermerhorn’s Team

Hunters For a Cure

Jennifer Kipphut

Markus Espinoza

Rick Gray

Hunting Down Cancer

Laura Kipphut

Charles Esten

Greater Bay Area Triathlon

Patric Hyland

Steven Kirz

ETrain

Greater LA Cycle Tour2Cure 2022

Conner Imbody

Kiss Cancer Goodbye

EY

Jordana Green

IQVIA

Nate Klein

Craig Eyers

Ava Gregory

Leslie Isler

Nicole Kline

Dan Fachner

Andy Grier

It’s In Our Blood 2022

Lance Knez

Faham Zakariaei

Eric Grossman

Jacks or Better

Knights to the Rescue

Michael Farmer

Mike Guadagnini

Nate Jacobs

Brian Kozera

Fearless Fighters

Albert Guida

Jags Hunt For A Cure

Sean Kramer

Gillian Fein

Wally Gundlach

Adeline Jansson

Alex Krasnec

Andrea Ferenchik

Vince Guthrie

Jay Juffre

Krazies Krushing Cancer

Fight Like Hell

Jorge Gutierrez

JB Strong

Katie Kreiser

Fight the Big C

Mark Hahn

JCStrong Legacy

Elaine Krueger

Fight With All Your Might

Hailey Peykoff

Brett Jenkins

Kuchars Kicking Out Cancer

Fighting for a Cure

Kristen Haire

Will Jenkins

Lynn Kuckelman

Fin’s Superheros

Summer Hall

Jenny Booyah and the Peachy Tribe

Stephanie Kuhlmann

FIS

Sarah Hamilton

Jessica Slick’s Team

Molly Kusma

Colin Fitzgibbons

Nancy Hamlin

Tara Johns

Felix Laboy

Florida Power & Light

Kaylin Hammer

Amy Johnson

Lucy Labruzzo

Natasha Fooman

Hannah Bonbright’s Team

Greg Johnson

Lace Up for LLS

For Eva

Deborah Harrington

Colleen Jones

Meghan Lansing

For the Lovette

Olivia Hart Panczner

Jeffrey Jones

Larry Lucchino

Force of Nature

Denise Hartmann

Sarah Jordan

Alana Kay Latiolais

Tom Forman

HCA Corporate

Josie’s Warriors

James Lau

Angela Frazier

Jim Healy

Julie Donaldson’s Campaign Team

Laura Lewis’ Campaign Team

Fresno Fighters

Hearts for A Cure

Just a Mile to Go

Eric Layne

Allie Fujarski

Hearts for Hope

Just Beat It

Kathy Leslie

Fundraising Flamingos

Abby Hegerfeld

Just Cure It

Emily Lewis

Carlen Funk

Helping Hands

Kaity Wachtel Team

Laura Lewis

Tracey Gairing

Heluva Good Hike!!

Jimmy Kalogeropoulos

Larry Lieberman

Kevin Galko

Jane Hennessy

Kirk Kaminsky

Lily Frakes

Grant Ganzi

Mike Hennessy

Kancer Krusaders

Lily Walton’s Team

Richard Garber

Mike Henninger

Kacie Kane

Emily Lipman Mahar

Garber Automotive

Nicholas Herrel

Richard Kaniewski

Josh Lippman

Vicky Garcia

Jesse Hertzberg

Karen Puente’s Campaign Team

Alex Lipsky

Courtney Gettings

Savannah Heskett Beck

Karen Weekly’s Team

LLS CUREsaders 2022

Aryanna Gharanfoli

Hikers4Life

Brian Keck

LLSaints

Rodrick Glass

Mark Hinkle

Lindsay Keyser

HLS for LLS

Akbar Khan

The Leukemia & Lymphoma Society

2022 Acknowledgments | 21

Big Dreams, BOLD PROGRESS

Lindsay Lococo

Sarina Moss

Pankaj Ramani

Erika Schimmel-Guiles

Lokahi

Bridget Murray

Rampart High School

Scott Schulman

Christopher Long

Erica Murray Donaldson

Paige Ramsey

Lindsey Schwartz

Brian Loughney

Greg and Beth Myers

Nayan Ranchhod

Richard Schwartz

Love and Light

Naomi Weaver’s Team

Richard Rayner

Diana Jamail Schwarzlose

Rachel Loveless

Natalie Warther’s Campaign Team

Rays of Hope

Helena Scott

Drew Lufkin

Gina Natoli

Charles Razook

Liz Sczudlo

Luke Andritsch’s Team

Rebecca Nazario

Red Ribbon Raisers

SDG&E/Sempra

Lymphomaniacs

Adam Neary

Donna Reed

SeaGen

Juliana MacTaggart

Carolyn Neary

Leslie Reed

Secure the Cure

Rosa Madera

Michelle Nemeth

Regan Kosteck’s Team

Peter Shankman

Madoff and Herz for Cancer Cures

Martha Newsom

Relentless for a Cure

Kevin Shannahan

Laura Maier

Matt Newsom

Meredith Rice

Mark Shannahan

Makenna Silviera

Bruce Newton

Aimee Rich

Jeff Shaw

Anita Malik

Allison Niday

Riders Of The Storm

Tom & Kathy Shea

Mana Ohana

Novant Health: Bond Beyond Blood

Julia Riesterer

Grace & Jack Sherner

Becky Mancuso-Winding

Matt O’Bryan

Maeva Riley

Natalie Sherod

Mariella’s Mission

Ochsner Legacy Team

Jennifer Ristic

Dave Shevsky

Mark Hahn’s Team

Friend of Chuck

Robbie’s Rebels Against Cancer

Charlotte Sigmund

Carol Markway

Okafor Family Foundation

Curtis Rocca

Silicon Valley LavaTeam 2022

Christy Marsengill

Haneen Omar

Rocco Pisani

Al Silva

Sarah Marshall

Ajith Pai

Estee Roe

Mike & Reid Simons

Lori Martin

Pammy’s PACK

Martin Romanelli

April Sirleaf

Valerie Maslow

Valerie Parker

Robert Rose

Alan Skarbnik

Jamie Mast

Kait Parrott

Sondra Rose

Shelly Skidmore

Jeff McClure

Parrott Pact

Mark Rubin

Todd Slingerland

Betsy McCorkle

Amanda Paul

Rubin 4 Research

Clay Smith

Julie McCormick

Kimberly Paulson

Janet Ruzich

Dona Jo Smith

Roger McCoy

Pele’s Pirates

Paul Ryan

Jason Smith

Katie McCurry

Rachel Peniche

Ryan Spahr Team

Korey Smith

McKesson

Robert J. Penta

Rye for a Cure

Soaring For a Cure 4.0

Edward McLaughlin

Amy Perlman

Melissa Sacco

Soaring For Hope

Megan’s Mission for the Cure

Chris Pero

SAIC

Brayden Sox

Tony Mehrtash

Stephanie Perri

Salesforce

Ryan Spahr

Heath Melton

Pharmacyclics | Janssen

Jeff Samuels

Brandi Sparks

Jeff Meyer

Lasondra Pontarelli

Joey Sanchez

Jessica Spielvogel

Meza’s Maniacs

Pop’s Warriors

Charlotte Sapir

Vivienne Spy

Miami Cure Mission

Michelle Porter

Sarina Moss’ Team

SqUAsh Cancer

Michael Annessa’s Campaign Team

Ben Poyant

Suma Satti

Meredith St. Amour

Mighty Mason’s Warriors

Nate Prather

Trevor Sava

Julie Stafford

Karl Miller

Alex Price

Savanna White

Darren Steenhoek

Christine Mills

Charity Price

Mike Scanlan

Matthew Steindecker

Moms In Training 2022

Ross Prussin

Cody Scarboro

Stephanie Perri’s Campaign

Josie Moreland

Karen Puente

Bryan Schachter

Clayton Stewart

Andrew Morgan

Racing for a Cure

Schardt on Cancer

Sticks for a Cure

Morgan Stanley

Kyle Ragsdale

Heather Stubblefield

Catrina Ralston

The Leukemia & Lymphoma Society

2022 Acknowledgments | 22

Big Dreams, BOLD PROGRESS

Gala Stude

Team Cancel Cancer

Team Fight for the Light

Team Madnick

Deborah Sturges

Team Cancer Combat Crew

Team Fighting for a Cure

Team Maggie Boucher

Keri Suhy

Team Cancer Crusaders

Team Fighting Irish Fighting Cancer 3.0

Team Making Bank

Robert “Sully” Sullivan

Team Cancer Crushers

Team Footsteps of Faith

Team May the Cure Be With You

Stuart Sullivan

Team CANcer Not CANTcer

Team Foxes for a Cure

Team MAYAmazing

Summit Mortgage Cancer Slayers

Team Cancer’s Kryptonite

Team Fredericksburg Fighters

Team MBA/Harpeth Hall

SuperHeroes Seeking a Cure

Team Canes 4 the Cure

Team Gators Beat Blood Cancer

Team Mighty Muskies

Survivor Strong

Team Capri D. Dessecker

Team Get Aboard

Team Mission 1.8

Suzannah Quayle

Team Carlon and Sendaydiego

Team Girls for a Cure

Team Mission to Remission

Jason Swift

Team Cavs for Cures

Team Gold 4.0

Team Moffitt

Take to the Limit and Beyond

Team Chaminade

Team Good Vibes Save Lives

Team N.E.D.

Scott Takinen

Team Change Cancer’s Course

Team Grand Slam

Team Newsom

Holly Tancar

Team Charlotte Shares the Love

Team Hayley & Katie

Team One Team One Heart

Brooke Teal

Team ChemoSabe

Team Hope

Team OneinaPREMILlion

Team 007 License to Cure

Team Children’s Cancer Crushers

Team Hope Heals

Team Out for Blood

TEAM 209

Team Clayton Stewart

Team Hope with Hoke

Team Pack for a Cure

Team 4 The Cure

Team Close Cares

Team Hoyas for a Cure

Team Panthers Against Cancer

Team 4Coach

Team Connect For A Cure

Team ICEE Hope

Team Penta

Team A(TL) Positive

Team Conor’s Crew

Team Impact

Team Perlman

Team ABCD

Team Conquer Cancer

Team In It to End It

Team ProCURE

Team Adeline’s Allies

Team CoUREage 3.0

Team Ironman

Team Rainbow Pony

Team Albstein

Team Coy-Burt

Team Jim Thorpe

Team Raise Hope Together

Team aMaising

Team Coyotes for a Cure 3.0

Team Julia

Team Raising Hope

Team Ann Cameron

Team Cracking a Cure

Team Just Beat It!

Team Rally 2 Raise 4 a Cure

Team Austin’s Army

Team Croga

Team Keeping the Faith

Team RamFam for a Cure

Team b.strong

Team CURE

Team Kenna

Team Ranchhod

Team Baking for a Cure

Team Khanfidence

Team Rays of Hope

Team Banking on a Cure

Team CURE (Cancer Underestimated Raines & Emily)

Team Kick Out Cancer

Team Rebecca

Team Barbara’s Angels

Team Cure It!

Team Kicking Cancer

Team Reed

Team BBC

Team CUREageous

Team Kipphut

Team Remission

Team Bears for a Cure

Team Cure’em with Kindness

Team KO Cancer

Team Rende Strong

Team Believe

Team Curesaders

Team KPMG

Team Believe in a Cure

Team CUREsaders 2.0

Team Kramer

Team S.W.A.T. - Surry Working Alongside Traci

Team Ben and The Cancer Kickers

Team Dancers Against Cancer

Team Kure for Kelly

Team S.W.A.T. 5.0

Team Beverly and Kennedy

Team Dancers Cancel Cancer

Team Lance & Parker

Team Saints for a Cure

Team Bleeding Hope

Team Dancers Ending Blood Cancers

Team Leukem

Team Blood Blasters

Team Danielle Chavez Trevino

Team Life is Good!

Team Saving Lives One Mom at a Time

Team Blood Busters

Team Difference Makers

Team Lindsay Lococo

Team Blood Squashers

Team Dunaway

Team Lioness

Team Blumenfeld Waterman

Team Ella

Team Lisa

Team Brave Up

Team Emma Rose

Team Live Like Charlie

Team Breaking Good

Team Ensure a Cure

Team LLS Warriors

Team Brightside

Team Ensure the Cure

Team Lulu & Hardin

Team Bucket List Cure Cancer

Team E’s Angels

Team Lurking for a Cure

Team Building For A Cure

Team Faith Over Fear

Team M.E.G.

Team Saving Our Youth Team Secure the Cure Team SF Bay Team Shoot for a Cure Team Silver Linings Team Sister Strong Team Sparks Team Stand Up in Strongsville

Team Fearless

The Leukemia & Lymphoma Society

2022 Acknowledgments | 23

Big Dreams, BOLD PROGRESS

Team Stangs for the Rangs

Team Will

Danielle Trevino

Watermark Retirement Communities

Team Steve Burnett

Team Wish

Triple Threat

Brad Watts

Team Strike Out Cancer

Team Women On A Mission

UCLA Health

WE CANcer-vive

Team Stronger Together

Team Woodward Strong

Jonathan Unger

We Fight 4 To-Marrow

Team Sully

Teens Tackling Cancer

United For A Cure

We WILL

Team Survive & Thrive

Kerby Teller

Until a Cure

Charlie Webber

Team Survivor

Texas Instruments-Dallas

Gustavo Valdespino

Cindy Webster

Team Survivors for a Cure

The Bloods

Danny Vance

Karen Weekly

Team Sutter Health

The Cancer Crushers

Jill Vaughan

Weez’s Warriors

Team SWAG

The Dream Team

Kyle Verkouteren

Theo Weiman

Team Swarming Cancer

The Howard Hughes Corporation

India Vielehr

Jessica Westlake Putrus

Team Takes a Village

The IncredibLLS

Jessica Visser

Whatever it Takes

Team Tapout Cancer

The Lymphoma Leaders

Andrea Voorhees

White Out Blood Cancer 2 Liv

Team Tawny

The Pink Boa’s

Kaity Wachtel

Gavin Williams

Team Teal Six

The Z Machine

Mari-Michelle Wahlstrom

Dwayne Wilson

Team Telescope

Throwing CUREballs

Walgreens

Joe Windler

Team The Answer for Cancer

Tilden-Coil Constructors Team KSmo

Jeremy Wallner

Dave Wooster

Team The Red Elephants

Jay Tilley

Wally Gundlach’s Team

Erin Zammett Ruddy

Team Tigers

Michael Tooley

Kendall Walsh

Zan’s Fans

Team Triumph

Ken Trainer

Cindy Walters

Ashley Zeldin

Team Tumornators

Treat and Defeat

Warriors for a Cure

Autumn Ziemba-McKenzie

Team Ultimate Cancer Fighters

Treen Charitable Events Treen

Natalie Warther

Anita Zucker

Team Uncover the Cure

Allen Wasinger

Team Unstoppable

The Leukemia & Lymphoma Society

2021 ACKNOWLEDGMENTS | 24

Big Dreams, BOLD PROGRESS

LEGACY CIRCLE Legacy Circle honors those who designate LLS as a beneficiary of their will, trust, retirement account or insurance policy, or fund a charitable gift annuity. We list our newest members below along with those whose bequests of $10,000 or more were received this year. .

Linda Amerling* Stephanie Arnold in memory of Stephen J. Arnold Lynn Aspey Stacy and Nicki Auman Jerry Baber* Betty Mae Baker* J. Leiter Bamberger* Ellen Barone* Audrey Barrett* James A. Beck Curtis Behr* Rosie Bethke

Harriet Dworetz*

Marjorie Lackey*

Ken Epstein

Norma Laine*

Jenna Sager in memory of Shirley Holland

Stephanie Estreen*

Elinore Lambert*

Angelena Sakalay*

Ehenborg Family Trust*

Betty Landeck*

Robert Sanders*

Beth Farishon*

Sharon Lessard*

Jeffrey Schiff*

Thomas Fitzpatrick

Morris z”l and Zita Liebermensch

Gail Secrist*

Marion Ford*

Richard Lieboff*

Marianne Seidenberger*

Cindy Furst*

Robert Lindholm

Bruno and Irma Selmi*

Laura Galbraith*

Brad and Marcie Lontz

Harold Sheroff*

William and Donalda Gibson in honor of Stephen William Gibson

Salvatore Lucchese*

Jay Silver

Margaret MacMurray*

Greg and Marcie Sinaiko

Scott Gildea in memory of Kayla Yearwood

Evelyn Maher*

Michael Smith*

Orlene Makinson*

Robert Snincak*

Linda M. Glover in memory of James Joseph Roberts

Richard Millich*

Anna May Snyder*

Brad and Ellen Molotsky Foundation

Scott Souba*

Elizabeth Muldoon*

Mark Steburg in memory of Mia Steburg

Jeffrey and Judy Greenhouse Dan and Debbie Hempy Rose Heminghaus* Lara and Matthew Hjortsberg James Hobbs*

Louis Naumann* Jeffrey and Paula Nelson Sylvia Novick* Margaret Olmazu*

Suzanne Strothkamp in memory of Harry M. Boyko, Jr. Steve Stumbris Zac Talmadge

James Carll*

Jeanne Hubbard and John Hubbard, PhD, FCP

Margaret Carson*

Richard Hughes*

Pam Olson*

Tim and Teresa Tanner in honor of Kayla Bradley

Brenda Cheney

Thomas Jacobson*

Emily Papapietro*

Herbert Vonderheide* Theodore Weber*

Larry Olson*

Suryama Joshi

Jeffrey Pollock

Stephen K. Collins

Ivan Kampel*

Fred and Cherie Pond

Paul Webskowski*

Melissa Tsaggaris Corso

Carol Kato*

Jeffrey Quan*

Ruth Widmer*

Karen Crain*

Susan Keisling*

Antoinette Ranalli*

Max and Joyce Wildman*

Bettye Cruse*

John Kellenyi*

Donald Rassaert*

Christiane Roussell and Jabari Willis

Charles Cuda

Lisa Pelletier Kennedy in memory of Joseph Pelletier and Kaylee Carew

Judy Redpath in memory of Raymond L. Lippman

Marvin Wolf*

John and Catherine Kennedy*

J. Landon Reeve*

Andrew Dale

Jacqueline Kent*

Brian and Catie Ross

Peter Day*

Wanda Kuntz*

Mark Royer*

Shawn and Elizabeth Clink

Lauren Rosenberg and Matt Dabrowski

Loretta DiRienzo* Peggy and Margaret Dupaquier*

The Leukemia & Lymphoma Society

Rosalinde Russell*

Robert Wolfe* Laurene Young* Michael Zemke* Anonymous (37)

* Deceased

2021 ACKNOWLEDGMENTS | 25

Big Dreams, BOLD PROGRESS

LEADERSHIP National Board Volunteers serve on our National Board of Directors providing leadership and governance to help find blood cancer cures.

Francie Heller Arabesque Asset Management Greeenwich, CT Lynne F. O’Brien McLean, VA

Regions and Executive Directors www.LLS.org/chapterfind

Officers Chairman of the Board Jeff Sachs Duluth, GA

Vice Chair Kathleen Meriwether Philadelphia, PA

Secretary/Treasurer Freda Wang Goldman Sachs Charlotte, NC

At Large Ruben Mesa, MD, FACP Mays Cancer Center San Antonio, TX

Board Members Richard Bagger Westfield, NJ Michele Cameron Allianz Global Investors US New York, NY Renzo Canetta, MD Madison, CT Casey Cunningham, MD Sante Ventures Houston, TX Christopher Flowers, MD MD Anderson Cancer Center Houston, TX Janice L. Gabrilove, MD. Icahn School of Medicine at Mt. Sinai New York, NY John Greene Vineti San Raphael, CA

The Leukemia & Lymphoma Society

Marla Persky WOMN LLC Ridgefield, CT Jim Reddoch, PhD Royalty Pharma Rye, NY

Susan Goss Brown SVP, Chief Diversity, Equity & Inclusion Officer - Field Development Bernard Arthur VP, Field - Field Development

Richard Rendina Rendina Healthcare Real Estate Jupiter, FL

Jennifer Marley Chair, LLSC

Robert Rosen Greyhawke Capital Advisors LLC West Palm Beach, FL

Andrea Freeman Northeast Territory Executive Director - Field Development

Bart Sichel New Hope, PA

Dee Dee Hines West Territory Executive Director - Field Development

Alessandra Tocco New York, NY

Executive Leadership Louis J. DeGennaro, PhD President & Chief Executive Officer Troy Dunmire Executive Vice President Chief Operating Officer JR Miller Executive Vice President Chief Financial Officer Gwen Nichols, MD Executive Vice President Chief Medical Officer Dale Nissenbaum Executive Vice President General Counsel & Chief of People

Liz Klug Central Territory Executive Director - Field Development Piper Medcalf Southeast Territory Executive Director - Field Development Central Valley Debbie Truhett Connecticut/Up NY Lori Glowacki Desert Laurie Susie Eastern Great Lakes Tina Massari-Thompson Eastern PA/Delaware Lauren Iannucci Georgia/South Carolina Amanda Yancey Greater Los Angeles Shannon Sullivan

Lower Plains Michelle Weigel Metro New York Andrea Freeman Michigan/Indiana Lori Morrison Mid-Atlantic Ria Freydberg Mountain Kristen Anderson New England Tara Greeley New Jersey Jana Boyer North Carolina/Virginia Emily Blust North Florida Melanie Johnson Northern California Sarah Clark Ohio River Valley Tom Carleton Pacific Northwest Katie Bolton Red River Leah Swanson South Central Texas Clarissa Flores South Florida Bobbie Jo Bates Southern California/HI Kathlene Seymour Tennessee/Alabama Jeff Parsley Upper Plains Kortney Hamm

Gulf Coast Billie Sue Parris Illinois Breana Shawver

2022 Acknowledgments | 26

The mission of The Leukemia & Lymphoma Society (LLS) is to cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families. Find out more at www.LLS.org.

1/23